Filter by:

www.blood.gov.au

/var/www/disclogs/web/web/showDomain.php (line 14)
  • reset($query->fetchAll(PDO::FETCH_ASSOC))
    9
    array
    • domain_name
      www.blood.gov.au
      16
      string
    • second_level_domain_name
      blood.gov.au
      12
      string
    • whois
      null
      null
    • dns
      {"CNAME": ["blood.gov.au."]}
      stringjsonobject
    • ip_whois
      null
      null
    • active
      true
      boolean
    • data_created_at
      2018-03-30 04:13:09.790107+00
      -7m 4w
      stringdatetime
    • data_updated_at
      2018-04-02 05:00:26.039301+00
      -7m 4w
      stringdatetime
    • https
      {"ocsp_response": {"version": "1", "responses": [{"certID": {"serialNumber": "53AD8A8AC656C0840D990C661D3E9B48", "hashAlgorithm": "sha1", "issuerKeyHash": "F07051DAD32A914F5277D78677740FCE711A6C22", "issuerNameHash": "5FDE1FB98448CCFDD9C8895B6DD19FEDA6D3FB11"}, "certStatus": "good", "nextUpdate": "Apr 4 21:56:14 2018 GMT", "thisUpdate": "Mar 28 21:56:14 2018 GMT"}], "producedAt": "Mar 28 21:56:14 2018 GMT", "responderID": "34EC26C9DA4FE234A9FB206C871D39E63DDF9A9D", "responseType": "Basic OCSP Response", "responseStatus": "successful"}, "certificate_chain": [{"issuer": {"commonName": "thawte EV SSL CA - G3", "countryName": "US", "organizationName": "thawte, Inc."}, "subject": {"commonName": "www.blood.gov.au", "countryName": "AU", "localityName": "Lyneham", "serialNumber": "Government Entity", "businessCategory": "Government Entity", "organizationName": "National Blood Authority", "stateOrProvinceName": "Australian Capital Territory", "jurisdictionCountryName": "AU"}, "keyUsage": "<KeyUsage(digital_signature=True, content_commitment=False, key_encipherment=True, data_encipherment=False, key_agreement=False, key_cert_sign=False, crl_sign=False, encipher_only=None, decipher_only=None)>", "subjectAltName": ["www.nba.gov.au", "nba.gov.au", "blood.gov.au", "www.blood.gov.au"], "not_valid_after": "2019-10-11T23:59:59", "basicConstraints": "<BasicConstraints(ca=False, path_length=None)>", "extendedKeyUsage": "<ExtendedKeyUsage([<ObjectIdentifier(oid=1.3.6.1.5.5.7.3.1, name=serverAuth)>, <ObjectIdentifier(oid=1.3.6.1.5.5.7.3.2, name=clientAuth)>])>", "not_valid_before": "2017-10-11T00:00:00", "authorityInfoAccess": "<AuthorityInformationAccess([<AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.1, name=OCSP)>, access_location=<UniformResourceIdentifier(value='http://ti.symcd.com')>)>, <AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.2, name=caIssuers)>, access_location=<UniformResourceIdentifier(value='http://ti.symcb.com/ti.crt')>)>])>", "certificatePolicies": "<CertificatePolicies([<PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.16.840.1.113733.1.7.48.1, name=Unknown OID)>, policy_qualifiers=['https://www.thawte.com/cps', <UserNotice(notice_reference=None, explicit_text='https://www.thawte.com/repository')>])>, <PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.23.140.1.1, name=Unknown OID)>, policy_qualifiers=None)>])>", "cRLDistributionPoints": "<CRLDistributionPoints([<DistributionPoint(full_name=[<UniformResourceIdentifier(value='http://ti.symcb.com/ti.crl')>], relative_name=None, reasons=None, crl_issuer=None)>])>", "authorityKeyIdentifier": "<AuthorityKeyIdentifier(key_identifier=b'\\xf0pQ\\xda\\xd3*\\x91ORw\\xd7\\x86wt\\x0f\\xceq\\x1al\"', authority_cert_issuer=None, authority_cert_serial_number=None)>", "signature_hash_algorithm": "sha256", "PrecertificateSignedCertificateTimestamps": "<PrecertificateSignedCertificateTimestamps([<cryptography.hazmat.backends.openssl.x509._SignedCertificateTimestamp object at 0x7f3321c11470>, <cryptography.hazmat.backends.openssl.x509._SignedCertificateTimestamp object at 0x7f3321c115f8>, <cryptography.hazmat.backends.openssl.x509._SignedCertificateTimestamp object at 0x7f3321c11a58>])>"}, {"issuer": {"commonName": "thawte Primary Root CA", "countryName": "US", "organizationName": "thawte, Inc.", "organizationalUnitName": "(c) 2006 thawte, Inc. - For authorized use only"}, "subject": {"commonName": "thawte EV SSL CA - G3", "countryName": "US", "organizationName": "thawte, Inc."}, "keyUsage": "<KeyUsage(digital_signature=False, content_commitment=False, key_encipherment=False, data_encipherment=False, key_agreement=False, key_cert_sign=True, crl_sign=True, encipher_only=None, decipher_only=None)>", "subjectAltName": ["<Name([<NameAttribute(oid=<ObjectIdentifier(oid=2.5.4.3, name=commonName)>, value='SymantecPKI-1-536')>])>"], "not_valid_after": "2023-10-30T23:59:59", "basicConstraints": "<BasicConstraints(ca=True, path_length=0)>", "not_valid_before": "2013-10-31T00:00:00", "authorityInfoAccess": "<AuthorityInformationAccess([<AccessDescription(access_method=<ObjectIdentifier(oid=1.3.6.1.5.5.7.48.1, name=OCSP)>, access_location=<UniformResourceIdentifier(value='http://t2.symcb.com')>)>])>", "certificatePolicies": "<CertificatePolicies([<PolicyInformation(policy_identifier=<ObjectIdentifier(oid=2.5.29.32.0, name=Unknown OID)>, policy_qualifiers=['https://www.thawte.com/cps'])>])>", "subjectKeyIdentifier": "<SubjectKeyIdentifier(digest=b'\\xf0pQ\\xda\\xd3*\\x91ORw\\xd7\\x86wt\\x0f\\xceq\\x1al\"')>", "cRLDistributionPoints": "<CRLDistributionPoints([<DistributionPoint(full_name=[<UniformResourceIdentifier(value='http://t1.symcb.com/ThawtePCA.crl')>], relative_name=None, reasons=None, crl_issuer=None)>])>", "authorityKeyIdentifier": "<AuthorityKeyIdentifier(key_identifier=b'{[E\\xcf\\xaf\\xce\\xcbz\\xfd1\\x92\\x1aj\\xb6\\xf3F\\xebWHP', authority_cert_issuer=None, authority_cert_serial_number=None)>", "signature_hash_algorithm": "sha256"}], "SSLV2 Cipher Suites": [], "SSLV3 Cipher Suites": [], "TLSV1 Cipher Suites": ["TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA", "TLS_RSA_WITH_AES_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_RC4_128_SHA", "TLS_RSA_WITH_RC4_128_MD5", "TLS_RSA_WITH_3DES_EDE_CBC_SHA"], "ocsp_response_status": 0, "TLSV1_1 Cipher Suites": [], "TLSV1_2 Cipher Suites": ["TLS_RSA_WITH_AES_256_CBC_SHA", "TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA", "TLS_RSA_WITH_AES_256_CBC_SHA256", "TLS_RSA_WITH_RC4_128_MD5", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA256", "TLS_ECDHE_RSA_WITH_AES_128_CBC_SHA256", "TLS_RSA_WITH_RC4_128_SHA", "TLS_RSA_WITH_AES_128_CBC_SHA", "TLS_RSA_WITH_3DES_EDE_CBC_SHA"], "TLSV1_3 Cipher Suites": [], "is_leaf_certificate_ev": true, "is_ocsp_response_trusted": true, "symantec_distrust_timeline": "SEPTEMBER_2018", "tls_server_name_indication": "www.blood.gov.au", "certificate_matches_hostname": true, "has_sha1_in_certificate_chain": false, "highest_ssl_version_supported": "TLSV1_2", "certificate_included_scts_count": 3, "has_anchor_in_certificate_chain": false, "openssl_cipher_string_supported": "AES128-SHA256", "is_certificate_chain_order_valid": true, "certificate_has_must_staple_extension": false}
      stringjsonobject
      • ocsp_response_status
        0
        integer
      • is_leaf_certificate_ev
        true
        boolean
      • is_ocsp_response_trusted
        true
        boolean
      • symantec_distrust_timeline
        SEPTEMBER_2018
        14
        string
      • tls_server_name_indication
        www.blood.gov.au
        16
        string
      • certificate_matches_hostname
        true
        boolean
      • has_sha1_in_certificate_chain
        false
        boolean
      • highest_ssl_version_supported
        TLSV1_2
        7
        string
      • certificate_included_scts_count
        3
        integer
      • has_anchor_in_certificate_chain
        false
        boolean
      • openssl_cipher_string_supported
        AES128-SHA256
        13
        string
      • is_certificate_chain_order_valid
        true
        boolean
      • certificate_has_must_staple_extension
        false
        boolean
titlepathsize_bytesword_countload_time
National Blood Authority | National Blood Authority / 73340 2030
10 Tips to Help Manage your Blood Product Inventory | National Blood Authority /10-tips-help-manage-your-blood-product-inventory 67968 1664 1.43177578
2015-16 NBA Annual Report | National Blood Authority /2015-16-nba-annual-report 56316 809 1.642576453
2015 National Immunohaematology Continuing Education (NICE) proceedings published | National Blood Authority /2015-national-immunohaematology-continuing-education-nice-proceedings-published 57208 829 1.023233198
2016: Closed Public Consultations | National Blood Authority /2016-closed-public-consultations 65634 1183 1.375653064
2017 Closed Public Consultations | National Blood Authority /2017-closed-public-consultations 74842 2642 1.654694173
ABC Health & Wellbeing: Why experts are rethinking blood transfusions by Bianca Nogrady | National Blood Authority /abc-health-wellbeing-why-experts-are-rethinking-blood-transfusions-bianca-nogrady 57298 834 1.486618246
Australian Bleeding Disorders Registry (ABDR) | National Blood Authority /abdr 74945 1683 0.806418164
Overview: About Blood | National Blood Authority /about-blood 61036 1188 1.722050623
Overview and Role of the NBA | National Blood Authority /about-nba 72126 1984 1.924415067
About NBA - In this Section | National Blood Authority /about-nba-menu 56264 832 0.96494059
Accessibility | National Blood Authority /accessibility 59553 1295 1.317763401
Access to subcutaneous immunoglobulin | National Blood Authority /access-subcutaneous-immunoglobulin 56922 872 0.959156996
6. BloodMove Achievements Since the 2013 Case Study | National Blood Authority /Achievements 68917 1440 1.707709906
Recognising, Managing and Reporting Adverse Events for Blood Products | National Blood Authority /adverse-events 63676 1300 1.50070013
4. Age of Blood | National Blood Authority /age-of-blood 67560 1315 1.427407979
1. Aims | National Blood Authority /aims 68321 1278 1.592174346
Anti-D | National Blood Authority /anti-d 61448 1129 1.51497951
Applications are now invited for research and development grants | National Blood Authority /applications-are-now-invited-research-and-development-grants 57789 802 1.567940055
Appointment of the General Manager of the National Blood Authority | National Blood Authority /appointment-general-manager-national-blood-authority 57353 913 0.886835335
Archived Legal Services Expenditure | National Blood Authority /archived-legal-services-expenditure 61498 984 0.9475009
Archived Media Releases | National Blood Authority /archived-media 58093 924 1.988782458
Assistant Minister for Health, Senator the Hon Fiona Nash, launches MyABDR | National Blood Authority /assistant-minister-health-senator-hon-fiona-nash-launches-myabdr 57309 848 0.931905588
Australian Health Provider Blood and Blood Products Charter | National Blood Authority /australian-health-provider-blood-and-blood-products-charter 69330 1377 1.635185599
Barcode specifications for blood & blood products | National Blood Authority /barcode-specifications-blood-blood-products 56877 844 1.233095887
Barcode Specifications | National Blood Authority /barcoding 71081 1849 1.515407893
Best Practice - In this Section | National Blood Authority /best-practice 59435 878 0.514382417
BloodSTAR | National Blood Authority /best-practice/immunoglobulin-products/bloodstar 68184 1247 2.031656429
BloodSTAR Privacy Controls | National Blood Authority /best-practice/immunoglobulin-products/bloodstar-privacy-controls 64934 1170 1.327338685
Big Red | National Blood Authority /big-red 60355 947 1.40265144
Bleeding Disorders | National Blood Authority /bleeding-disorders 67900 1534 1.694021423
Blood Measures and Data Linkage | National Blood Authority /blood-measures-and-data-linkage 61659 1113 1.63554937
4. BloodMove features and strengths | National Blood Authority /bloodMove-features-strengths 77384 2192
BloodMove Platelets - a successful system to significantly reduce platelet wastage | National Blood Authority /bloodmove-platelets 69432 1412 1.626316539
BloodMove Project Case Study | National Blood Authority /bloodmove-project-case-study 75701 1670 2.418668704
BloodMove wins ACHS Quality Improvement Award | National Blood Authority /bloodmove-wins-achs-quality-improvement-award 56916 846 0.94035051
BloodNet | National Blood Authority /bloodnet 63786 1218 1.483009253
Certified Interfaces | National Blood Authority /bloodnet/certified-interfaces 64929 1118 2.414607943
Fresh Component Health Provider Discards Report (FATE007) | National Blood Authority /bloodnet-fate007 58611 985 0.954496769
Fresh Blood Orders and Issues Extract (FUL010e) | National Blood Authority /bloodnet-ful010e 57473 921 1.452379898
National Health Provider Inventory Level Report (INV001) | National Blood Authority /bloodnet-inv001 58365 1026 1.012137898
Issues Report (INV002) | National Blood Authority /bloodnet-inv002 57131 893 1.080583035
BloodNet Laboratory Information System (LIS) Interfaces | National Blood Authority /bloodnet/lis-interfaces 70936 1368 1.403808378
BloodNet LIS Interface Specifications | National Blood Authority /bloodnet-lis-interface-specifications 56589 819 1.036984279
BloodNet Milestone at the Fiona Stanley Hospital, WA | National Blood Authority /bloodnet-milestone-fiona-stanley-hospital-wa 60064 1115 1.377190187
BloodNet News | National Blood Authority /bloodnet-news 63014 960 1.413286019
BloodNet News December 2015 out now | National Blood Authority /bloodnet-news-december-2015-out-now 56519 823 0.922754342
National Health Provider Feedback Report (REC001) | National Blood Authority /bloodnet-rec001 57637 949 1.0387244
BloodNet Reports | National Blood Authority /bloodnet-reports 58342 1064 1.456397555
BloodNet Specifications for Interfacing | National Blood Authority /bloodnet-specifications-interfacing 64287 1038 1.380338246
BloodNet Support Materials | National Blood Authority /bloodnet-support-materials 76140 1179 1.592924482
BloodPortal | National Blood Authority /bloodportal 62163 973
Where can I find more information? | National Blood Authority /blood-service-implementing-isbt-128-labelling-june-2018 58002 823 1.371839443
BloodSTAR | National Blood Authority /bloodstar 67696 1178 1.37255602
BloodSTAR calculator for adjusting Ig dose for ideal body weight | National Blood Authority /bloodstar-calculator-adjusting-ig-dose-ideal-body-weight 64939 1320 1.060410058
BloodSTAR Facility Administrator* | National Blood Authority /bloodstar-facility-administrator 61492 1420 1.565429725
BloodSTAR News April 2016 | National Blood Authority /bloodstar-news-april-2016 67810 2062 1.067054474
BloodSTAR News April 2018 | National Blood Authority /bloodstar-news-april-2018 78416 2724 1.781618193
BloodSTAR News August 2016 | National Blood Authority /bloodstar-news-august-2016 64920 1684 1.263544223
BloodSTAR News December 2016 | National Blood Authority /bloodstar-news-december-2016 66762 1930 1.078567093
BloodSTAR News February 2017 | National Blood Authority /bloodstar-news-feb-2017 70257 1959 1.044759076
BloodSTAR News February 2016 | National Blood Authority /bloodstar-news-february-2016 62900 1493 1.025089408
BloodSTAR News July 2017 | National Blood Authority /bloodstar-news-july-2017 69060 2013 0.985201063
BloodSTAR News June 2016 | National Blood Authority /bloodstar-news-june-2016 74457 2481 1.115736448
BloodSTAR News March 2016 | National Blood Authority /bloodstar-news-march-2016 71601 2172 1.140860699
BloodSTAR News May 2016 | National Blood Authority /bloodstar-news-may-2016 66670 2036 1.159141768
BloodSTAR News November 2016 | National Blood Authority /bloodstar-news-november-2016 65699 1745 1.015514236
BloodSTAR News October 2017 | National Blood Authority /bloodstar-news-october-2017 74038 1908 1.565195566
BloodSTAR Privacy Controls | National Blood Authority /bloodstar-privacy-controls 64595 1101 1.494666409
BloodSTAR Support Materials | National Blood Authority /bloodstar-support-materials 66060 957
BloodSTAR User Registration NOW OPEN | National Blood Authority /bloodstar-user-registration-now-open 56428 803 0.889116059
Overview: Blood Systems | National Blood Authority /blood-systems 70307 1535 2.919129174
Burnside War Memorial Hospital Case Study | National Blood Authority /burnside-hospital-case-study 72142 1578 1.582931504
Burnside War Memorial Hospital case study | National Blood Authority /burnside-war-memorial-hospital-case-study 56956 862 1.048856532
C1 esterase inhibitor concentrate | National Blood Authority /c1-esterase-inhibitor-concentrate 57827 974 0.881461353
Case Studies | National Blood Authority /case-studies 73515 2231 0.311289284
Changes to National Product List | National Blood Authority /changes-national-product-list 61001 956
Change to Supply Arrangement for Domestic Intravenous Immunoglobulin | National Blood Authority /change-supply-arrangement-domestic-intravenous-immunoglobulin 57316 860 0.972306942
National Blood Authority Customer Service Charter | National Blood Authority /charter 61688 1446 1.120006971
Closed Public Consultations | National Blood Authority /closed-public-consultations 63033 1102 2.613052484
2013: Closed Public Consultations | National Blood Authority /closed-public-consultations-2013 64232 1370 1.482316651
2014: Closed Public Consultations | National Blood Authority /closed-public-consultations-2014 66636 1663 1.035963575
2015: Closed Public Consultations | National Blood Authority /closed-public-consultations-2015 63896 1316 1.616930744
Committees and Working Groups | National Blood Authority /committees-and-working-groups 58386 922 0.880758843
Conference: Patient Blood Management as a standard of care in Australia: Past, Present and Future | National Blood Authority /conference-patient-blood-management-standard-care-australia-past-present-and-future 57864 896 1.261155962
Consensus statements on clinical indications for CMV Seronegative Blood Components | National Blood Authority /consensus-statements-clinical-indications-cmv-seronegative-blood-components 57250 838 1.33869927
Consensus statements on Clinicial Indications for Platelets open for public consultation | National Blood Authority /consensus-statements-clinicial-indications-platelets-open-public-consultation 57284 837 0.849050685
Contact Us | National Blood Authority /contact-us 58167 893 1.41602871
Contracts with Suppliers | National Blood Authority /contracts-suppliers 66965 1509 1.722402838
The Conversation | National Blood Authority /conversation 60382 920 1.559211989
Copyright | National Blood Authority /copyright 57870 1010 1.018273798
Creating an authorisation request | National Blood Authority /creating-authorisation-request 64836 965 1.45609077
Current Vacancies | National Blood Authority /current-vacancies 56732 846 1.348713316
Data Analysis and Reporting | National Blood Authority /data-analysis-reporting 76501 1398 0.931622191
Data Governance | National Blood Authority /data-governance 64886 1367 0.797884513
Overview: Data & Research | National Blood Authority /data-research 62114 1108 2.669932489
Disclaimer | National Blood Authority /disclaimer 59136 1334 2.061312092
Dispenser | National Blood Authority /dispenser 70354 1102 1.932886302
Download PBM Guidelines: Module 6 - Neonatal and Paediatrics now | National Blood Authority /download-pbm-guidelines-module-6-neonatal-and-paediatrics-now 57885 801 1.337347981
Education and Training | National Blood Authority /education-and-training 69470 1695 1.549841522
Eligibility Requirements for Working at the National Blood Authority | National Blood Authority /eligibility-requirements-working-national-blood-authority 62843 1457 1.088169196
Working at the National Blood Authority | National Blood Authority /employment 61483 1068 0.969972275
Benefits of Working at the National Blood Authority | National Blood Authority /employment-benefits 63966 1514 1.052987935
Overview: Ensuring Supply | National Blood Authority /ensuring-supply 61897 1171 2.442517945
Facility Administrator | National Blood Authority /facility-administrator 66905 1000 1.913044694
Facility Certification Process | National Blood Authority /facility-certification-process 74392 2117 1.591901644
Fibrinogen Concentrate Approval Under National Blood Arrangements | National Blood Authority /fibrinogen-concentrate-approval-under-national-blood-arrangements 58111 974 1.001407435
Fit for Surgery | Fit for Life | National Blood Authority /fit-surgery-fit-life 57459 808 2.025198634
Fit For Surgery: Managing Iron Deficiency Anaemia | National Blood Authority /fit-surgery-managing-iron-deficiency-anaemia 67106 1413 1.733683313
Freedom of Information | National Blood Authority /freedom-information 66246 2063 1.21475645
Freedom of Information Disclosure Log | National Blood Authority /freedom-information-disclosure-log 61741 1267 1.545555578
Fresh Blood Product Procurement | National Blood Authority /fresh-blood-procurement 67851 1427 1.50701506
Fresh Blood Products | National Blood Authority /fresh-blood-products 63740 1391 1.963455577
Fresh Blood Products | National Blood Authority /fresh-blood-products-0 61002 1010 2.786348094
Further Updates to Supply Arrangements for Domestic Intravenous Immunoglobulin | National Blood Authority /further-updates-supply-arrangements-domestic-intravenous-immunoglobulin 57454 857 1.472112254
5. The future | National Blood Authority /future 67478 1183 1.529886055
Future Arrangements for Imported Plasma and Recombinant Products (IPRP) | National Blood Authority /future-arrangements-imported-plasma-and-recombinant-products-iprp 57049 834 0.90488996
Future Initiatives | National Blood Authority /future-initiatives 66856 1216 1.493431271
Governance Arrangements and Key Stakeholders | National Blood Authority /governance-arrangements 65462 1615 1.286026487
Governmental Compliance | National Blood Authority /governmental-compliance 63440 1310 1.030517056
Guidance for the Provision of Intraoperative Cell Salvage | National Blood Authority /guidance-provision-intraoperative-cell-salvage 56758 827 1.037073979
Guidelines for the management of haemophilia in Australia | National Blood Authority /haemophilia-guidelines 63795 1075 1.486337405
Haemovigilance Reporting | National Blood Authority /haemovigilance-reporting 78715 2362 1.603381477
For Health Professionals | National Blood Authority /health-professionals 61252 1295 1.547136286
How to Apply for a Position at the National Blood Authority | National Blood Authority /how-apply-position-national-blood-authority 61644 1270 1.019241597
Hunter Area Pathology Service Case Study | National Blood Authority /hunter-area-pathology-service-case-study 69249 1419 1.695847401
Guidance for the Provision of Intraoperative Cell Salvage | National Blood Authority /ics 72191 1556 1.072408129
National Immunoglobulin Governance Committees | National Blood Authority /Ig-committees 73747 1671 1.604388263
Immunoglobulin authorisation request forms | National Blood Authority /Ig-forms 70194 1543 1.209554004
Immunoglobulin Products | National Blood Authority /Ig-governance 64456 1131 3.927917564
National Immunoglobulin Governance Program | National Blood Authority /Ig-program 70600 1668 1.344139152
Ig Governance Criteria and Progress Updates | National Blood Authority /Ig-program-updates 69958 1867 1.366462579
3. Implementation and hub-spoke arrangements | National Blood Authority /Implementation 69391 1374 2.570756014
Implementation | National Blood Authority /implementation-0 73443 2043 1.564587225
Implementing the ELP Protocol | National Blood Authority /implementing-elp-protocol 71125 1855 1.654971392
Implementing the PBM Guidelines | National Blood Authority /implementing-pbm 89239 2767 1.677438259
Imported Plasma and Recombinant Products Future Arrangements | National Blood Authority /imported-plasma-and-recombinant-products-future-arrangements 57022 835 0.932869615
Imported Plasma and Recombinants Products Request for Tender | National Blood Authority /imported-plasma-and-recombinant-products-request-tender 57295 878 0.978589339
Imported plasma and recombinant product supply contracts | National Blood Authority /imported-plasma-and-recombinant-product-supply-contracts 57017 850 0.837234813
Imported Plasma & Recombinant Product Tender Outcomes (Request for Tender 02/2013) | National Blood Authority /imported-plasma-recombinant-product-tender-outcomes-request-tender-022013-0 57379 852 0.946853447
Imported Products | National Blood Authority /imported-products 63581 1200 1.350190578
Improved outcomes | National Blood Authority /improved-outcomes 70749 1766 1.679294969
Managing Blood and Blood Product Inventory - Acknowledgements and References | National Blood Authority /int-mgt-guideline-acknowledgements-and-references 63298 1362 0.999836655
Intraoperative Cell Salvage (ICS) Guidance now available | National Blood Authority /intraoperative-cell-salvage-ics-guidance-now-available 57142 871 0.966163454
Access to Intravenous Immunoglobulin (IVIg) | National Blood Authority /Intravenous-Ig 73511 2039 2.872504423
Introduction, Background and Aim | National Blood Authority /introduction-background-and-aim 66180 1120 1.423447218
Managing Blood Product Inventory | National Blood Authority /inventory-management 66837 1243
Managing Blood and Blood Product Inventory Guidelines for Australian Health Providers | National Blood Authority /inv-mgt-guideline 67365 1246 1.708300272
Managing Blood and Blood Product Inventory - 10 Tips to Help Manage Your Blood Product Inventory | National Blood Authority /inv-mgt-guideline-10-to-tips-help-manage-your-blood-product-inventory 58585 1037 0.785546605
Managing Blood and Blood Product Inventory - Introduction | National Blood Authority /inv-mgt-guideline-introduction 60089 1210 1.309250519
Managing Blood and Blood Product Inventory - Inventory Management Basics | National Blood Authority /inv-mgt-guideline-inventory-management-basics 60290 1271 1.003254042
Module 1: Managing Blood and Blood Product Transfers - Implementation | National Blood Authority /inv-mgt-guideline-module-1-implementation 74114 2882 0.881117804
Module 1: Managing Blood and Blood Product Transfers - Preparation | National Blood Authority /inv-mgt-guideline-module-1-preparation 66021 1922 1.188774796
Module 1: Managing Blood and Blood Product Transfers - Scope and Introduction | National Blood Authority /inv-mgt-guideline-module-1-scope-and-introduction 59845 1137 1.239248945
Managing Blood and Blood Product Inventory - Tip 10: Have a patient blood management program & Implementation | National Blood Authority /inv-mgt-guideline-tip-10-and-implementation 60836 1137 1.007143954
Managing Blood and Blood Product Inventory - Tip 1: Understand Your Inventory | National Blood Authority /inv-mgt-guideline-tip-1-understand-your-inventory 61331 1311 0.996852258
Managing Blood and Blood Product Inventory - Tip 2: Provide Expert Training | National Blood Authority /inv-mgt-guideline-tip-2-provide-expert-training 58961 1074 0.881360439
Managing Blood and Blood Product Inventory - Tip 3: Set Appropriate Inventory Levels | National Blood Authority /inv-mgt-guideline-tip-3-set-appropriate-levels 66450 2096 0.323240688
Managing Blood and Blood Product Inventory - Tip 4: Keep Procedures Simple & Tip 5: Build Collaborative Relationships | National Blood Authority /inv-mgt-guideline-tip-4-and-tip-5 60161 1168 0.957870312
Managing Blood and Blood Product Inventory - Tip 6: Use Oldest Product First & Tip 7: Optimise Cross Matching Procedures | National Blood Authority /inv-mgt-guideline-tip-6-and-tip-7 60877 1295 1.135262782
Managing Blood and Blood Product Inventory - Tip 8: Maintain all Equipment Appropriately & Tip 9: Have a Plan to Conserve Inventory in Times of Shortage | National Blood Authority /inv-mgt-guideline-tip-8-and-tip-9 60722 1217 1.07390162
3. Involved Haematologists | National Blood Authority /involved-haematologists 67233 1230 1.566861529
Information Publication Scheme (IPS) | National Blood Authority /ips 73305 1544
Iron product choice and dose calculation guide for adults | National Blood Authority /iron-product-choice-and-dose-calculation-guide-adults 61797 986 0.867222629
Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia | National Blood Authority /ivig-criteria 90357 3967 1.6080693
Intravenous Immunoglobulin (IVIg) Request Forms | National Blood Authority /ivig-request-forms 69898 1077 1.509119093
Jurisdictional Blood Committee (JBC) | National Blood Authority /jbc 61217 1120 0.841615949
John Hunter Hosptial - a casestudy in reducing wastage | National Blood Authority /john-hunter-hosptial-casestudy-reducing-wastage 57100 867 0.957026625
July International Trends Report now available | National Blood Authority /july-international-trends-report-now-available 56926 839 0.964824707
Jurisdictional Reporting | National Blood Authority /jurisdictional-reporting 61233 1027 2.689148201
The Laboratory Process | National Blood Authority /laboratory-process 66773 1258 1.22196674
Public consultation feedback and subsequent changes to the Criteria | National Blood Authority /list-conditions 92132 1526 1.451013605
Liverpool Hospital RFID Case Study | National Blood Authority /liverpool-hospital-rfid-case-study 75747 2353 0.674494902
Liverpool Hospital RFID Case Study | National Blood Authority /liverpool-hospital-rfid-case-study-0 56605 832 0.919938517
Managing blood at Burnside Hospital? | National Blood Authority /managing-blood-burnside-hospital 67864 1261 2.269741331
Manufacturing costs on all blood component labels | National Blood Authority /manufacturing-costs-all-blood-component-labels 61002 1499 0.889199184
For Media | National Blood Authority /media 63917 1058
Prescriber / Nurse Practitioner (Medical Officer) | National Blood Authority /medical-officer 76625 1292 1.429312479
Meeting Standard 7 | National Blood Authority /meeting-standard-7 68577 1377 1.450442619
Module 1: Managing Blood and Blood Product Transfers | National Blood Authority /module-1-managing-blood-and-blood-product-transfers 67614 1166 1.587816597
Module 2: Ig Inventory Management Guidelines | National Blood Authority /module-2-ig-inventory-management-guidelines 64231 1003 1.616960177
Module 2: Managing Intravenous and Subcutaneous Immunoglobulin Inventory - Introduction | National Blood Authority /module-2-managing-intravenous-and-subcutaneous-immunoglobulin-inventory 58130 927 0.956772786
Module 2: Managing Intravenous and Subcutaneous Immunoglobulin Inventory - Dispensing | National Blood Authority /module-2-managing-intravenous-and-subcutaneous-immunoglobulin-inventory-dispensing 61143 1364 0.962285716
Module 2: Managing Intravenous and Subcutaneous Immunoglobulin Inventory - Keeping Appropriate Inventory Levels | National Blood Authority /module-2-managing-intravenous-and-subcutaneous-immunoglobulin-inventory-keeping-appropriate 58972 1062 1.0062488
Module 2: Managing Intravenous and Subcutaneous Immunoglobulin Inventory open for consultation | National Blood Authority /module-2-managing-intravenous-and-subcutaneous-immunoglobulin-inventory-open-consultation 57517 851 0.960702402
Module 2: Managing Intravenous and Subcutaneous Immunoglobulin Inventory - Ordering | National Blood Authority /module-2-managing-intravenous-and-subcutaneous-immunoglobulin-inventory-ordering 64303 1672 1.171397367
Module 2: Managing Intravenous and Subcutaneous Immunoglobulin Inventory - References | National Blood Authority /module-2-managing-intravenous-and-subcutaneous-immunoglobulin-inventory-references 57482 851 1.070242968
Module 2: Managing Intravenous and Subcutaneous Immunoglobulin Inventory - Role of the Dispenser | National Blood Authority /module-2-managing-intravenous-and-subcutaneous-immunoglobulin-inventory-role-dispenser 58945 1034 1.029048421
Monitoring International Trends for the Blood Sector | National Blood Authority /monitoring-international-trends-blood-sector 76254 1405 1.749358718
MyABDR | National Blood Authority /myabdr 69000 1270 0.879672631
MyABDR is now available for use by people with bleeding disorders | National Blood Authority /myabdr-now-available-use-people-bleeding-disorders 57037 869 0.898900446
National Archives recognises the NBA as a world-class digital achiever | National Blood Authority /national-archives-recognises-nba-world-class-digital-achiever 57128 841 0.97798867
National Blood Authority Blood and Blood Product Purchases | National Blood Authority /national-blood-authority-blood-and-blood-product-purchases 59937 1032 1.175369884
National Blood Sector Research and Development Pilot Program | National Blood Authority /national-blood-sector-research-and-development-pilot-program 57233 857 0.934702035
National Policy: Access to Government Funded Immunoglobulin Products in Australia - Second Edition Now Available | National Blood Authority /national-policy-access-government-funded-immunoglobulin-products-australia-second-edition-now 58955 852 1.34881002
National Policy: Access to Government Funded Immunoglobulin Products in Australia | National Blood Authority /national-policy-to-ig 67844 1273 0.883564235
What Blood Products are Supplied - National Product List | National Blood Authority /national-product-list 81857 1947 1.564263736
National Standard for Blood and Blood Products Safety and Quality | National Blood Authority /national-standard 65109 1268 1.583614607
NBA Annual Report 2012-13 now available | National Blood Authority /nba-annual-report-2012-13-now-available 56873 844 1.323553911
NBA Annual Report 2013-14 | National Blood Authority /nba-annual-report-2013-14 56289 809 0.942358492
National Blood Authority Board | National Blood Authority /nba-board 72536 2912 1.168437339
NBA ICT team awarded Australian Government 'ICT Professional Team of the Year" | National Blood Authority /nba-ict-team-awarded-australian-government-ict-professional-team-year 57557 873 1.087413098
National Blood Supply Contingency Plan | National Blood Authority /nbscp 66790 1508 1.359639063
New case study now available - Pathology Queensland | National Blood Authority /new-case-study-now-available-pathology-queensland 57324 870 0.874914012
News 2017 | National Blood Authority /news 56299 825 0.924314226
News 2013 | National Blood Authority /news-2013 59765 1011 1.005013545
News 2014 | National Blood Authority /news-2014 59238 992 1.024021219
News 2015 | National Blood Authority /news-2015 56688 852 1.137978508
News 2016 | National Blood Authority /news-2016 59907 1046 1.612991171
Access to Normal Human Immunoglobulin (NHIg) | National Blood Authority /NHIg 68428 1449 1.536794049
National Immunohaematology Continuing Education (NICE) | National Blood Authority /nice 63798 1331 1.646964931
National Immunohaematology Continuing Education (NICE) Presentations 2012 | National Blood Authority /nice-2012 69733 1443 1.073941582
National Immunohaematology Continuing Education (NICE) Proceedings 2013 | National Blood Authority /nice-2013 75766 1408 1.067413379
National Immunohaematology Continuing Education (NICE) Proceedings 2008 | National Blood Authority /nice-proceedings-2008 63810 1332 1.090551508
National Immunohaematology Continuing Education (NICE) Proceedings 2009 | National Blood Authority /nice-proceedings-2009 63859 1358 1.127420922
National Immunohaematology Continuing Education (NICE) Proceedings 2010 | National Blood Authority /nice-proceedings-2010 65327 1291 0.972829952
National Immunohaematology Continuing Education (NICE) Proceedings 2011 | National Blood Authority /nice-proceedings-2011 69175 1476 1.070874123
National Immunohaematology Continuing Education (NICE) Proceedings 2014 | National Blood Authority /nice-proceedings-2014 72402 1328 1.200447752
National Immunohaematology Continuing Education (NICE) Proceedings 2015 | National Blood Authority /nice-proceedings-2015 71435 1473 0.980126112
National Inventory Management Framework (NIMF) | National Blood Authority /nimf 75396 1727 1.947183677
National Managed Fund (NMF) | National Blood Authority /nmf 61129 1005 0.564065392
/non-CMS/videos/Transfusionrisks1080p.mp4 145554018 0 0.640067178
/non-CMS/videos/Transfusionrisks1080pSubs.mp4 142200087 0 0.585638956
/non-CMS/videos/Transfusionrisks480p.mp4 35434814 0 0.292473
/non-CMS/videos/Transfusionrisks480pSubs.mp4 37959388 0 0.283518748
/non-CMS/videos/Transfusionrisks720p.mp4 65407687 0 0.580236811
/non-CMS/videos/Transfusionrisks720pSubs.mp4 69152123 0 0.24323448
Nurse/ Midwife | National Blood Authority /nurse-midwife 72138 1207 1.93035514
Blood Operations Centre (BOC) | National Blood Authority /ops-centre 60565 1010 1.611600429
Other information for patients about blood and blood products | National Blood Authority /other-information 59451 1117 0.965700475
Out Now | National Blood Authority /out-now 57175 793 0.753287651
Out Now: Guidelines for the management of haemophilia in Australia | National Blood Authority /out-now-guidelines-management-haemophilia-australia 57064 852 0.915700966
Patient Blood Management Guidelines: Module 6 – Neonatal and Paediatrics | National Blood Authority /out-now-pbm-module-6-neonatal-and-paediatrics 56920 840 0.877846454
Overview: Publications & Tools | National Blood Authority /overview-publications-tools 60178 1019 2.281426189
Paediatric and Neonatal Iron Deficiency Anaemia Guide | National Blood Authority /paediatric-and-neonatal-iron-deficiency-anaemia-guide 57613 847 0.827856941
Pathology Queensland Case Study | National Blood Authority /pathology-queensland-case-study 69453 1509 0.724053166
Pathology Service Provider Obligations Under NSQHS Standard 7 – Blood and Blood Products | National Blood Authority /pathology-service-provider-obligations-nsqhs 58806 1086 1.481364519
The Patient Blood Management Guidelines Companions | National Blood Authority /patient-blood-management-guidelines-companions 81238 1480 1.540306148
Patient Blood Management (PBM) | National Blood Authority /patient-blood-management-pbm 69343 1295
Patient Blood Management (PBM) Guidelines development process | National Blood Authority /patient-blood-management-pbm-guidelines-development-process 59737 1161 1.291057088
Patient factsheets and resources | National Blood Authority /patient-factsheets-and-resources 67591 1154 1.347458464
For Patients | National Blood Authority /patients 61177 1061 1.93703821
Patient Videos | National Blood Authority /patient-videos 56209 806 1.059202585
Patient Blood Management Guidelines | National Blood Authority /pbm-guidelines 69445 1433 2.505522876
Patient Blood Management Guidelines Progress Update : January 2018 | National Blood Authority /pbm-guidelines-updates 70040 1658 2.225272513
Patient Blood Management Guidelines: Launches | National Blood Authority /pbm-launch 73060 1336 1.272984286
Patient Blood Management Guidelines: Module 1 Critical Bleeding/Massive Transfusion | National Blood Authority /pbm-module-1 69472 1435 1.804888956
Patient Blood Management Guidelines: Module 2 Perioperative | National Blood Authority /pbm-module-2 70482 1457 1.668284044
Patient Blood Management Guidelines: Module 3 Medical | National Blood Authority /pbm-module-3 68615 1378 1.459686959
Patient Blood Management Guidelines: Module 4 Critical Care | National Blood Authority /pbm-module-4 69272 1401 1.645281288
Patient Blood Management Guidelines: Module 5 Obstetrics and Maternity | National Blood Authority /pbm-module-5 68874 1412 1.646866573
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics | National Blood Authority /pbm-module-6 70960 1479 1.532390224
Plasma and Recombinant Product Procurement | National Blood Authority /plasma-and-recombinant-product-procurement 73688 1952 1.49432068
Plasma and Recombinant Products | National Blood Authority /plasma-and-recombinant-products 70750 2380 1.613379296
Platelets | National Blood Authority /platelets 62182 1011 1.277247803
Point of Care Coagulation Testing Case Study | National Blood Authority /point-care-coagulation-testing-case-study-prince-charles-hospital-brisbane 66218 1128 1.258872844
Post Implementation | National Blood Authority /post-implementation 70240 1799 1.520005935
Potential Data Breach - Red Cross Blood Service | National Blood Authority /potential-data-breach-red-cross-blood-service 57611 960 0.802889086
Preoperative Anaemia Identification, Assessment and Management Case Study | National Blood Authority /preoperative-anaemia-identification-assessment-and-management-case-study 65635 1087 1.506663535
Preoperative Bleeding Risk Assessment and Intervention Resource | National Blood Authority /preoperative-bleeding-risk-assessment-and-intervention-resource 59956 984 0.919248288
National Blood Authority /print/40 6734 228 1.276447942
Send by email | National Blood Authority /printmail/40 56489 803 1.142137476
Privacy | National Blood Authority /privacy 73421 2841 1.700800809
Privacy of patient information in ABDR and MyABDR | National Blood Authority /privacy-info-abdr-myabdr 76373 1550 1.684237115
Procurement and Tenders | National Blood Authority /procurement 64007 1360 1.252412137
Publication Order Form | National Blood Authority /publication-order-form 76577 1087 1.626763091
Public Consultation | National Blood Authority /public-consultation 58915 860 1.638174513
Public consultation 2017 - proposed changes to the Criteria’ | National Blood Authority /Public-consultation-2017-proposed-changes-to-the-Criteria 85166 1255 1.363441178
Public Consultation on Clinical Audit Tools | National Blood Authority /public-consultation-clinical-audit-tools 56632 826 0.97803801
Public Consultation Now Open for Blood and Blood Product Transfers | National Blood Authority /public-consultation-now-open-blood-and-blood-product-transfers 57176 859 1.045963706
Public Interest Disclosure | National Blood Authority /public-interest-disclosure 66188 1837 1.643564126
NBA Annual Report 2006-2007 /pubs/0607report/ 15575 1022 0.125779041
NBA Annual Report 2006-2007 /pubs/0607report/06-07-annualreport.html 15575 1022 0.122415436
NBA Annual Report 2006-2007 /pubs/0607report/part1-1.html 17371 1963 0.114347117
NBA Annual Report 2006-2007 /pubs/0607report/part1-2.html 5527 225 0.125223175
NBA Annual Report 2006-2007 /pubs/0607report/part1-3.html 12797 1274 0.113632549
NBA Annual Report 2006-2007 /pubs/0607report/part1-4.html 25371 2672 0.120875526
NBA Annual Report 2006-2007 /pubs/0607report/part1.html 4240 119 0.115154879
NBA Annual Report 2006-2007 /pubs/0607report/part2-1.html 4001 103 0.114302453
NBA Annual Report 2006-2007 /pubs/0607report/part2-2.html 5317 289 0.118249785
NBA Annual Report 2006-2007 /pubs/0607report/part2-3.html 7698 502 0.115007212
NBA Annual Report 2006-2007 /pubs/0607report/part2-4.html 10828 970 0.11643383
NBA Annual Report 2006-2007 /pubs/0607report/part2-5.html 5722 317 0.124407876
NBA Annual Report 2006-2007 /pubs/0607report/part2-6.html 15034 1267 0.116592622
NBA Annual Report 2006-2007 /pubs/0607report/part2.html 4653 156 0.122810409
NBA Annual Report 2006-2007 /pubs/0607report/part3-1.html 10584 808 0.118333389
NBA Annual Report 2006-2007 /pubs/0607report/part3-2.html 21947 2347 0.121809231
NBA Annual Report 2006-2007 /pubs/0607report/part3-3.html 15469 1390 0.114028416
NBA Annual Report 2006-2007 /pubs/0607report/part3-4.html 14763 1420 0.115681002
NBA Annual Report 2006-2007 /pubs/0607report/part3-5.html 7988 546 0.164370011
NBA Annual Report 2006-2007 /pubs/0607report/part3-6.html 6002 352 0.134171464
NBA Annual Report 2006-2007 /pubs/0607report/part3-7.html 12944 1241 0.115730518
NBA Annual Report 2006-2007 /pubs/0607report/part3-8.html 8786 658 0.119330408
NBA Annual Report 2006-2007 /pubs/0607report/part3.html 4259 97 0.114362016
NBA Annual Report 2006-2007 /pubs/0607report/part4-1.html 6321 372 0.158895269
NBA Annual Report 2006-2007 /pubs/0607report/part4-2.html 6001 349 0.12466586
NBA Annual Report 2006-2007 /pubs/0607report/part4-3.html 5796 359 0.12602394
NBA Annual Report 2006-2007 /pubs/0607report/part4-4.html 4716 173 0.114690419
NBA Annual Report 2006-2007 /pubs/0607report/part4-5.html 4230 118 0.113777827
NBA Annual Report 2006-2007 /pubs/0607report/part4-6.html 4347 154 0.114423055
NBA Annual Report 2006-2007 /pubs/0607report/part4.html 4167 85 0.127273339
NBA Annual Report 2006-2007 /pubs/0607report/part5-1.html 4141 116 0.114603592
NBA Annual Report 2006-2007 /pubs/0607report/part5-2.html 5652 315 0.114260631
NBA Annual Report 2006-2007 /pubs/0607report/part5-3.html 3603 47 0.114744712
NBA Annual Report 2006-2007 /pubs/0607report/part5-4.html 3865 93 0.113834218
NBA Annual Report 2006-2007 /pubs/0607report/part5-5.html 4332 117 0.115399083
NBA Annual Report 2006-2007 /pubs/0607report/part5-6.html 6505 339 0.114290185
NBA Annual Report 2006-2007 /pubs/0607report/part5-7.html 14744 1411 0.11478836
NBA Annual Report 2006-2007 /pubs/0607report/part5.html 4101 84 0.115354242
NBA Annual Report 2006-2007 /pubs/0607report/part6.html 3761 58 0.114311811
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/ 13335 761 0.123673935
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/index.html 13335 761 0.123462238
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part1-1.html 10295 1310 0.113866214
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part1-2.html 13257 1725 0.113190374
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part1-3.html 16284 1622 0.114633418
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part1-4.html 21278 1928 0.125773133
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part1.html 2354 140 0.119719516
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part2-1.html 3239 255 0.1314858
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part2-2.html 5020 502 0.123670898
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part2-3.html 6966 565 0.114894361
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part2-4.html 5981 637 0.11632857
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part2-5.html 12576 1339 0.114968629
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part2.html 2274 116 0.120339651
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-1.html 5302 359 0.114014846
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-2.html 10832 806 0.113704657
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-3.html 27330 3253 0.116788619
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-4.html 16356 1637 0.121184784
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-5.html 28430 3475 0.115103296
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-6.html 25148 2485 0.114889189
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-7.html 3253 248 0.11491921
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-8.html 7610 819 0.126685921
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3-9.html 18037 2056 0.114605029
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part3.html 2615 123 0.114420985
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part4-1.html 10364 615 0.114370291
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part4-2.html 5279 470 0.116161368
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part4-3.html 3655 350 0.114112242
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part4-4.html 1967 115 0.113752245
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part4-5.html 2400 145 0.114479678
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part4-6.html 2246 143 0.113323488
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part4.html 2283 97 0.128878003
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part5.html 11737 1328 0.122794945
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6-1.html 5954 319 0.120497533
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6-2.html 4294 408 0.115593744
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6-3.html 1724 73 0.115603791
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6-4.html 1800 88 0.124175843
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6-5.html 3299 179 0.130932838
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6-6.html 8897 639 0.113945322
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6-7.html 15101 1465 0.11503731
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part6.html 2273 98 0.135943932
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part7-1.html 1860 80 0.113416157
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part7-2.html 7941 781 0.113965635
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part7-3.html 4812 215 0.112539254
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part7-4.html 9484 523 0.113719102
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part7-5.html 5494 235 0.113735541
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part7.html 1953 71 0.115616141
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/part8.html 1810 81 0.115711415
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/transmittal.html 4091 251 0.114454882
National Blood Authority: Annual Report 2007-2008 /pubs/0708report/userguide.html 5657 449 0.114720759
National Blood Authority Australia - Annual Report 2008–2009 /pubs/0809report/ 1257 15 0.126207593
National Blood Authority Australia - Annual Report 2008–2009 /pubs/0809report/prelims/contents.html 15397 978 0.235451361
National Blood Authority Australia - Annual Report 2009-10 /pubs/0910report/ 917 14 0.123273403
National Blood Authority Australia - Annual Report 2009-10 /pubs/0910report/prelims/contents.html 18730 1196 0.246073181
National Blood Authority Australia - Annual Report 2010-11 /pubs/1011report/ 1002 14 0.135275893
National Blood Authority Australia - Annual Report 2010-11 /pubs/1011report/prelims/contents.html 17381 1098 0.241088184
National Blood Authority Australia - Annual Report 2011-12 /pubs/1112report/ 859 14 0.164152025
National Blood Authority Australia - Annual Report 2011-12 /pubs/1112report/prelims/contents.html 18895 1040 0.232652042
National Blood Authority Annual Report 2013 /pubs/1213report/html/ 11384 468 0.506183864
National Blood Authority Annual Report 2013 /pubs/1213report/html/index.html 11384 468 0.226882958
National Blood Authority Annual Report 2013 - Letter of Transmittal /pubs/1213report/html/letter-of-transmittal.html 8013 381 0.945256154
National Blood Authority Annual Report 2013 - Organisation at a Glance /pubs/1213report/html/part1/1.1.html 19887 1138 0.232369435
National Blood Authority Annual Report 2013 - General Manager's Review /pubs/1213report/html/part1/1.2.html 16624 1482 0.234621518
National Blood Authority Annual Report 2013 - NBA Board and Report /pubs/1213report/html/part1/1.3.html 12552 938 0.123301285
National Blood Authority Annual Report 2013 - Part 1: Overview of the NBA and the Blood Sector /pubs/1213report/html/part1/1.html 6765 211 0.141339509
National Blood Authority Annual Report 2013 - Performance Reporting /pubs/1213report/html/part2/2.1.html 13848 713 0.239528561
National Blood Authority Annual Report 2013 - Objective 1. Secure the supply of blood and blood products /pubs/1213report/html/part2/2.2.html 49880 4013 0.126068692
National Blood Authority Annual Report 2013 - Objective 2: Improve risk management and blood sector performance /pubs/1213report/html/part2/2.3.html 28578 3105 0.308523917
National Blood Authority Annual Report 2013 - Objective 3. Promote the safe and efficient use of blood and blood products /pubs/1213report/html/part2/2.4.html 23770 2450 0.137187719
National Blood Authority Annual Report 2013 - Part 2: Performance /pubs/1213report/html/part2/2.html 6864 220 0.199533196
National Blood Authority Annual Report 2013 - Governance Structure /pubs/1213report/html/part3/3.1.html 12452 866 0.143118806
National Blood Authority Annual Report 2013 - Operational Planning /pubs/1213report/html/part3/3.2.html 8578 380 0.120110463
National Blood Authority Annual Report 2013 - Customer Service Charter /pubs/1213report/html/part3/3.3.html 7432 285 0.113149723
National Blood Authority Annual Report 2013 - External Scrutiny /pubs/1213report/html/part3/3.4.html 7071 259 0.121733635
National Blood Authority Annual Report 2013 - Fraud Control /pubs/1213report/html/part3/3.5.html 8316 368 0.115686359
National Blood Authority Annual Report 2013 - Human Resources and People Management /pubs/1213report/html/part3/3.6.html 24243 1891 0.115114855
National Blood Authority Annual Report 2013 - Part 3: Management and Accountability /pubs/1213report/html/part3/3.html 7019 206 0.138766563
National Blood Authority Annual Report 2013 - Financial Management /pubs/1213report/html/part4/4.1.html 10203 626 0.120732806
National Blood Authority Annual Report 2013 - Financial Performance /pubs/1213report/html/part4/4.2.html 15327 943 0.124313688
National Blood Authority Annual Report 2013 - Assets Management /pubs/1213report/html/part4/4.3.html 7097 266 0.115223239
National Blood Authority Annual Report 2013 - Purchasing /pubs/1213report/html/part4/4.4.html 10709 584 0.137807794
National Blood Authority Annual Report 2013 - Financial Statements /pubs/1213report/html/part4/4.5.html 295052 13705 0.130808691
National Blood Authority Annual Report 2013 - Part 4: Financial Management /pubs/1213report/html/part4/4.html 6833 200 0.137975675
National Blood Authority Annual Report 2013 - Appendix 1. Committee and Board Member Profiles /pubs/1213report/html/part5/5.1.html 16148 1591 0.286790411
National Blood Authority Annual Report 2013 - Appendix 2. Fresh Blood Components Supploed Under Contract by the Blood Service in 2013-13 /pubs/1213report/html/part5/5.2.html 10439 412 0.151178682
National Blood Authority Annual Report 2013 - Appendix 3. Plasma and Recombinant Products Supplied Under Contract in 2012-13 /pubs/1213report/html/part5/5.3.html 18137 682 0.114927933
National Blood Authority Annual Report 2013 - Appendix 4. Mandatory Reporting /pubs/1213report/html/part5/5.4.html 30403 2212 0.122682313
National Blood Authority Annual Report 2013 - Appendix 5. List of Requirements /pubs/1213report/html/part5/5.5.html 22364 1124 0.127128513
National Blood Authority Annual Report 2013 - Appendix 6. Acronyms and Abbreviations /pubs/1213report/html/part5/5.6.html 14346 511 0.114808079
National Blood Authority Annual Report 2013 - Part 5: Appendices /pubs/1213report/html/part5/5.html 7169 232 0.128718506
National Blood Authority Annual Report 2013 /pubs/1314report/html/index.html 11424 454 0.149524498
National Blood Authority Annual Report 2013 - Letter of Transmittal /pubs/1314report/html/letter-of-transmittal.html 8029 378 0.490756062
National Blood Authority Annual Report 2014 - Organisation at a Glance /pubs/1314report/html/part1/1.1.html 18400 1267 0.284859146
National Blood Authority Annual Report 2013 - General Manager's Review /pubs/1314report/html/part1/1.2.html 14952 1261 0.576431284
National Blood Authority Annual Report 2013 - NBA Board and Report /pubs/1314report/html/part1/1.3.html 13132 1018 0.204454812
National Blood Authority Annual Report 2013 - Part 1: Overview /pubs/1314report/html/part1/1.html 6611 188 0.383673505
National Blood Authority Annual Report 2013 - Performance Reporting /pubs/1314report/html/part2/2.1.html 14511 725 0.745919797
National Blood Authority Annual Report 2013 - Objective 1. Secure the supply of blood and blood products /pubs/1314report/html/part2/2.2.html 50377 4506 0.475465485
National Blood Authority Annual Report 2013 - Objective 2: Improve risk management and blood sector performance /pubs/1314report/html/part2/2.3.html 26530 2624 0.473358952
National Blood Authority Annual Report 2013 - Objective 3. Promote the safe and efficient use of blood and blood products /pubs/1314report/html/part2/2.4.html 21660 2000 0.119515661
National Blood Authority Annual Report 2013 - Part 2: Performance /pubs/1314report/html/part2/2.html 6806 211 0.340534925
National Blood Authority Annual Report 2013 - Governance Structure /pubs/1314report/html/part3/3.1.html 11687 748 0.135595218
National Blood Authority Annual Report 2013 - Operational Planning /pubs/1314report/html/part3/3.2.html 9989 548 0.123347226
National Blood Authority Annual Report 2013 - Customer Service Charter /pubs/1314report/html/part3/3.3.html 7434 277 0.130372684
National Blood Authority Annual Report 2013 - External Scrutiny /pubs/1314report/html/part3/3.4.html 7068 256 0.120216761
National Blood Authority Annual Report 2013 - Fraud Control /pubs/1314report/html/part3/3.5.html 8272 357 0.131346794
National Blood Authority Annual Report 2013 - Human Resources and People Management /pubs/1314report/html/part3/3.6.html 22495 1649 0.142308656
National Blood Authority Annual Report 2013 - Part 3: Management and Accountability /pubs/1314report/html/part3/3.html 6839 197 0.130612582
National Blood Authority Annual Report 2013 - Financial Management /pubs/1314report/html/part4/4.1.html 10230 622 0.149704143
National Blood Authority Annual Report 2013 - Financial Performance /pubs/1314report/html/part4/4.2.html 15360 930 0.138370587
National Blood Authority Annual Report 2013 - Assets Management /pubs/1314report/html/part4/4.3.html 6821 222 0.297677918
National Blood Authority Annual Report 2013 - Purchasing /pubs/1314report/html/part4/4.4.html 10500 575 0.243302137
National Blood Authority Annual Report 2013 - Financial Statements /pubs/1314report/html/part4/4.5.html 29420 727 0.257293807
National Blood Authority Annual Report 2013 - Part 4: Financial Management /pubs/1314report/html/part4/4.html 6742 188 0.126689824
National Blood Authority Annual Report 2013 - Appendix 1. Committee and Board Member Profiles /pubs/1314report/html/part5/5.1.html 17842 1809 0.132224253
National Blood Authority Annual Report 2013 - Appendix 2. Fresh Blood Components Supploed Under Contract by the Blood Service in 2013-13 /pubs/1314report/html/part5/5.2.html 10654 403 0.159600954
National Blood Authority Annual Report 2013 - Appendix 3. Plasma and Recombinant Products Supplied Under Contract in 2012-13 /pubs/1314report/html/part5/5.3.html 19392 769 0.123584564
National Blood Authority Annual Report 2013 - Appendix 4. Mandatory Reporting /pubs/1314report/html/part5/5.4.html 28772 1974 0.227817908
National Blood Authority Annual Report 2013 - Appendix 5. List of Requirements /pubs/1314report/html/part5/5.5.html 27221 1442 0.269136665
National Blood Authority Annual Report 2013 - Appendix 6. Acronyms and Abbreviations /pubs/1314report/html/part5/5.6.html 15374 536 0.274530158
National Blood Authority Annual Report 2013 - Part 5: Appendices /pubs/1314report/html/part5/5.html 6990 223 0.122991554
Home | National Blood Authority Annual Report 2014-15 /pubs/1415report/index.html 18593 451 0.293489015
/pubs/1415report/sites/default/files/publication/nba-annual-report-2014-15.pdf 11833146 0 0.253862197
Index | National Blood Authority Annual Report 2014-15 /pubs/1516report/index.html 19191 459 0.271965388
/pubs/1516report/sites/default/files/publication/nba-annual-report-2015-16.pdf 7986664 0 0.145435899
Letter of Transmittal | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/home/letter-transmittal.html 19835 441 0.610841028
PART 1: Overview | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/home/part-1-overview.html 17358 226 0.13636274
PART 2: Annual Performance | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/home/part-2-annual-performance.html 18147 254 0.254541996
PART 3: Management and Accountability | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/home/part-3-management-and-accountability.html 18478 255 0.150091314
PART 4: Financial Management | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/home/part-4-financial-management.html 17875 226 0.132292402
PART 5: Appendices | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/home/part-5-appendices.html 18561 264 0.146401993
Home | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/index.html 18961 356 0.575558341
Chief Executive Review | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-1-overview/chief-executive-review.html 35157 2634 0.274569486
NBA Board and Report | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-1-overview/nba-board-and-report.html 24125 959 1.000110302
Organisation at a glance | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-1-overview/organisation-glance.html 34114 1422 0.314264315
Annual Performance Reporting Statement | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-2-annual-performance/annual-performance-reporting-statement.html 36767 1719 0.116816333
Objective 1. Secure the supply of blood and blood products | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-2-annual-performance/objective-1-secure-supply-blood-and-blood-products.html 76451 4207 0.116024322
Objective 2. Improve risk management and blood sector performance | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-2-annual-performance/objective-2-improve-risk-management-and-blood-sector-performance.html 51612 4248 0.12231393
Objective 3. Promote the safe and efficient use of blood and blood products | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-2-annual-performance/objective-3-promote-safe-and-efficient-use-blood-and-blood-products.html 45395 3204 0.152201885
Customer Service Charter | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-3-management-and-accountability/customer-service-charter.html 18981 308 0.115455596
External Scrutiny | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-3-management-and-accountability/external-scrutiny.html 18937 301 0.116040963
Fraud Control | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-3-management-and-accountability/fraud-control.html 19551 390 0.11492173
Human Resources and People Management | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-3-management-and-accountability/human-resources-and-people-management.html 47437 1980 0.113870041
Planning Framework | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-3-management-and-accountability/planning-framework.html 22502 609 0.117984422
Structure, Governance and Authority in the Blood Sector | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-3-management-and-accountability/structure-governance-and-authority-blood-sector.html 27309 1178 0.175343778
Assets Management | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-4-financial-management/assets-management.html 17789 244 0.127402356
Financial Management | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-4-financial-management/financial-management.html 22457 660 0.120964583
Financial Performance | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-4-financial-management/financial-performance.html 32701 969 0.114341568
Financial Statements | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-4-financial-management/financial-statements.html 17671 230 0.118819835
Purchasing | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-4-financial-management/purchasing.html 23901 714 0.128925202
Appendix 1. Committee and Board Member Profiles | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-5-appendices/appendix-1-committee-and-board-member-profiles.html 32142 2168 0.114979625
Appendix 2. Fresh Blood Components Supplied Under Contract by the Blood Service in 2016-17 | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-5-appendices/appendix-2-fresh-blood-components-supplied-under-contract-blood-service-2016-17.html 25548 455 0.118268305
Appendix 3. Plasma And Recombinant Products Supplied Under Contract in 2016-17 | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-5-appendices/appendix-3-plasma-and-recombinant-products-supplied-under-contract-2016-17.html 46899 888 0.132419467
Appendix 4. Mandatory Reporting | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-5-appendices/appendix-4-mandatory-reporting.html 53725 2083 0.122906302
Appendix 5. List of Requirements | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-5-appendices/appendix-5-list-requirements.html 63070 1987 0.123828754
Appendix 6. Acronyms and Abbreviations | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-5-appendices/appendix-6-acronyms-and-abbreviations.html 27127 642 0.129049851
Index | National Blood Authority Annual Report 2016–17 /pubs/1617report.v2/part-5-appendices/index.html 38755 1807 0.12948962
/pubs/1617report.v2/sites/default/files/publication/nba-annual-report-2016-17.pdf 8815313 0 0.222832373
Australian Haemovigilance Report : Australian Haemovigilance Report /pubs/2013-haemovigilance/ 29022 1343 0.116747583
Australian Haemovigilance Report : Australian Haemovigilance Report /pubs/2013-haemovigilance/index.html 29022 1343 0.786047354
Australian Haemovigilance Report : APPENDIX I: INTERNATIONAL CONTEXT /pubs/2013-haemovigilance/section10.html 12344 962 0.217656254
Australian Haemovigilance Report : APPENDIX II: DEFINITIONS IN HAEMOVIGILANCE /pubs/2013-haemovigilance/section11.html 19057 1183 0.161898935
Australian Haemovigilance Report : APPENDIX III: DEFINITIONS OF DONOR ADVERSE EVENTS /pubs/2013-haemovigilance/section12.html 25416 940 0.222462181
Australian Haemovigilance Report : APPENDIX IV: NSW HAEMOVIGILANCE DATA FOR 2009-10 AND 2010-11 /pubs/2013-haemovigilance/section13.html 25978 913 0.183707451
Australian Haemovigilance Report : APPENDIX V: ODDS RATIO DATA FOR DONOR VIGILANCE /pubs/2013-haemovigilance/section14.html 26046 356 0.144865755
Australian Haemovigilance Report : ABBREVIATIONS AND ACRONYMS /pubs/2013-haemovigilance/section15.html 34643 647 0.122051005
Australian Haemovigilance Report : REFERENCES /pubs/2013-haemovigilance/section16.html 41435 1587 0.124740374
Australian Haemovigilance Report : Content Index /pubs/2013-haemovigilance/section17.html 83713 2593 0.147926401
Australian Haemovigilance Report : ACKNOWLEDGEMENTS /pubs/2013-haemovigilance/section2.html 10290 401 0.23678185
Australian Haemovigilance Report : MESSAGE FROM THE GENERAL MANAGER OF THE NATIONAL BLOOD AUTHORITY /pubs/2013-haemovigilance/section3.html 7367 456 0.179735858
Australian Haemovigilance Report : EXECUTIVE SUMMARY /pubs/2013-haemovigilance/section4.html 20317 1008 0.148922746
Australian Haemovigilance Report : PART 01 BLOOD USE AND HAEMOVIGILANCE SYSTEMS /pubs/2013-haemovigilance/section5.html 146256 10044 0.236879731
Australian Haemovigilance Report : PART 02 PREVIOUS AUSTRALIAN HAEMOVIGILANCE DATA AND PERFORMANCE /pubs/2013-haemovigilance/section6.html 41778 2874 0.576710351
Australian Haemovigilance Report : PART 03 DONOR VIGILANCE /pubs/2013-haemovigilance/section7.html 62426 2216 0.130563536
Australian Haemovigilance Report : PART 04 HAEMOVIGILANCE DATA FOR 2009-10 AND 2010-11 /pubs/2013-haemovigilance/section8.html 629110 13391 0.127862249
Australian Haemovigilance Report : PART 05 RECOMMENDATIONS /pubs/2013-haemovigilance/section9.html 25229 1463 0.150634385
Australian Haemovigilance Report | Australian Haemovigilance Report Data for 2011-12 and 2012-13 /pubs/2015-haemovigilance/index/australian-haemovigilance-report.html 13019 265 0.150477404
Australian Haemovigilance Report | Australian Haemovigilance Report Data for 2011-12 and 2012-13 /pubs/2015-haemovigilance/index.html 11877 253 0.154209257
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/ 1377 14 0.125703757
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/contents.html 10619 469 0.900093679
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/executive-summary.html 12551 1306 0.551145478
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/foreword.html 11662 984 0.555460402
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/index2.html 8804 771 0.666220106
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/index_of_conditions.html 20941 588 0.327225644
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/introduction.html 20593 1999 1.260175259
Criteria for the clinical use of intravenous immunoglobulin in Australia - Second Edition /pubs/ivig/production-of-normal-immunoglobulins.html 15532 1621 0.336146069
Criteria for the clinical use of intravenous immunoglobulin in Australia - Quick Reference Guide /pubs/ivig/qrg/ 1349 17 0.114702035
Introduction /pubs/ivig/qrg/1-contents/introduction.html 10772 1033 0.216247283
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/ 840 11 0.257860104
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/clinical/4.2.html 18774 969 0.401292595
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/clinical/4.3.html 7135 295 0.371564386
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/clinical/4.6.html 15039 814 0.231471669
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/clinical/4.7.html 8166 264 0.183034838
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/clinical/4.8.html 8243 406 0.418584767
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/clinical/4.9.html 6367 442 0.385927163
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/contents.html 19723 1121 1.002957351
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/directions/5.1.7.html 5136 308 0.261632854
Patient Blood Management Guidelines: Module 1 /pubs/pbm/module1/index.html 840 11 0.807544
Patient Blood Management Guidelines: Module 2 /pubs/pbm/module2/ 729 8 0.937411845
Patient Blood Management Guidelines: Module 2 /pubs/pbm/module2/contents.html 28949 1042 0.741739405
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/ 555 1 0.914355794
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/abbreviations_and_acronyms.html 5985 303 0.224433578
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/appendix_a.html 20124 1715 0.212873016
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/appendix_b.html 9518 684 0.203472636
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/appendix_c.html 9632 958 0.198735817
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/appendix_d.html 8148 696 0.215519814
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/appendix_e.html 3519 130 0.199967897
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/appendix_f.html 51341 3882 0.205257953
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_1_1.html 4309 185 0.184788599
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_1_2.html 4695 288 0.199173167
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_1_3.html 6130 405 0.26179898
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_1.html 6691 469 0.315767419
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_2_1.html 4045 215 0.333701489
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_2_2.html 7606 635 0.206540144
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_2_3.html 11509 722 0.300481288
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_2.html 4608 202 0.211458076
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_1_1.html 7790 388 0.331610316
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_1_2.html 6763 337 0.216158515
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_1_3.html 6761 302 0.193536768
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_1_4.html 6940 347 0.200243355
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_1_5.html 7446 331 0.234508397
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_1.html 4406 277 0.243470784
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_2_1.html 9637 721 0.203606703
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_2_2.html 10053 608 0.224734945
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_2_3.html 6228 334 0.196874726
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_2_4.html 6547 313 0.210244082
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_2_5.html 6958 359 0.22980768
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_2.html 4203 238 0.246827245
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3_1.html 17904 1126 0.252360925
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3_2.html 12039 725 0.244883645
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3_3.html 19509 1305 0.257839853
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3_4.html 5995 222 0.256316219
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3_5.html 7280 412 0.20586282
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3_6.html 7451 345 0.200315699
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3_7.html 3413 132 0.189672208
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_3.html 6293 534 0.268565029
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_4_1.html 9397 599 0.239044152
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_4_2.html 6931 400 0.242141379
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_4_3.html 14705 965 0.259715374
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_4.html 3679 163 0.20774218
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_5_1.html 9616 574 0.205442582
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_5_2.html 8377 511 0.20620803
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_5_3.html 10464 744 0.199947459
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_5.html 5084 350 0.221477632
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_6_1.html 10650 821 0.19609617
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_6_2.html 7625 568 0.203519864
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3_6.html 5179 377 0.221222163
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_3.html 8700 436 0.204096673
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_4_1_1.html 4957 308 0.177216966
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_4_1_2.html 4132 239 0.182983597
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_4_1_3.html 7441 607 0.189952592
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_4_2.html 5339 386 0.248610021
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_4.html 3984 127 0.22756782
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_5_1.html 4455 269 0.272724063
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_5_2.html 3324 128 0.220811458
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_5.html 4334 242 0.232379047
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/chapter_6.html 7171 627 0.189169853
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/contents.html 16757 841 0.821275545
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/executive_summary.html 4670 287 0.240188906
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/figures.html 3262 96 0.229553087
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/index.html 555 1 0.815483931
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/patient_blood_management_guidelines.html 4233 210 0.200615093
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/references.html 71329 6458 0.314666706
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/summary_of_recommendations_and_practice_points.html 44849 1894 0.415297727
Patient Blood Management Guidelines: Module 3 /pubs/pbm/module3/tables.html 3809 123 0.471367135
Patient Blood Management Guidelines: Module 4 – Critical Care /pubs/pbm/module4/ 315283 16361 1.04926308
Patient Blood Management Guidelines: Module 5 – Obstetrics and Maternity /pubs/pbm/module5/ 551103 32596 0.565681705
Patient Blood Management Guidelines: Module 6 – Neonatal and Paediatrics /pubs/pbm/module6/ 1470350 85037 0.226362913
The Royal Children's Hospital Melbourne Extended Life Plasma Protocol Case Study | National Blood Authority /rch-elp-case-study 70184 1568 0.635915438
R&D Grant FAQ's | National Blood Authority /rd-grant-faqs 56238 809 1.00985565
Red Cell Diagnostic Product Procurement | National Blood Authority /red-cell-diagnostic-reagents-product-procurement 66198 1183 3.42815037
Red Cell Usage | National Blood Authority /red-cell-usage 63148 1193 1.416367493
Redcliffe | National Blood Authority /redcliffe 68894 1602 1.414611155
Registering your facility for BloodSTAR* | National Blood Authority /registering-your-facility-bloodstar 107251 1801 3.031985907
Release of Australian Bleeding Disorders Registry Annual Report | National Blood Authority /release-australian-bleeding-disorders-registry-annual-report 57108 840 1.081475594
Where do I Report Adverse Events | National Blood Authority /reporting-adverse-events 65503 1520 1.269296854
Request for Tender for Supply of Imported Immunoglobulin | National Blood Authority /request-tender-supply-imported-immunoglobulin 57253 877 0.955286716
Request for Tender for Supply of Red Cell Diagnostic Products | National Blood Authority /request-tender-supply-red-cell-diagnostic-products 57187 874 0.910157638
Research and Development | National Blood Authority /research-and-development 66033 1404 1.7690665
Research and Development Pilot Project | National Blood Authority /research-and-development-pilot-project 57377 919 0.892654671
Search for Publications and Tools | National Blood Authority /resources 85828 1540 2.091607056
Results | National Blood Authority /results 68965 1416 1.587184114
Results of Round 1 National Blood Sector Research and Development Pilot | National Blood Authority /results-round-1 65558 1302 1.670463947
Results of Round 2 National Blood Sector Research and Development Pilot | National Blood Authority /results-round-2-national-blood-sector-research-and-development-pilot 64207 1120 1.311481165
Review and change management | National Blood Authority /review-and-change-management 70772 1708 1.651122371
Review of the Authorisation and Clinical Governance Framework for Intravenous Immunoglobulin (2012) | National Blood Authority /review-auth-clinical-gov 67160 1345 1.602474981
Risk Management | National Blood Authority /risk-management 61047 973 1.372016049
Round 1 research and development grants announced | National Blood Authority /round-1-research-and-development-grants-announced 56842 840 0.900675715
The Royal Australasian College of Surgeons recommends minimising the use of blood transfusion in the Choosing Wisely Campaign. | National Blood Authority /royal-australasian-college-surgeons-recommends-minimising-use-blood-transfusion-choosing-wisely 59293 983 0.966696808
Royal Brisbane and Women’s Hospital | National Blood Authority /royal-brisbane-hospital 72670 1847 0.869116447
Royal Children's Hospital Extended Life Plasma Case Study | National Blood Authority /royal-childrens-hospital-extended-life-plasma-case-study 57222 879 0.973950583
Supply Arrangements for Imported Plasma and Recombinant Products /rss.xml 13654 1153 0.751673962
Safety of Blood Products | National Blood Authority /safety-blood-products 61943 1332 1.407270063
SAN Pathology Case Study | National Blood Authority /san-pathology-case-study 76706 2367 1.626332148
Access to Subcutaneous Immunoglobulin (SCIg) | National Blood Authority /SCIg 72647 1603 1.464358263
Subcutaneous Immunoglobulin (SCIg) Request Forms | National Blood Authority /scig-request-forms 67230 1039 0.669464308
The Second Edition of the National Policy: Access to Government-Funded Immunoglobulin Products in Australia has been released. | National Blood Authority /second-edition-national-policy-access-government-funded-immunoglobulin-products-australia-has-been 57859 880 0.821873834
Sector Monitoring 2011 | National Blood Authority /sector-monitoring-2011 57207 815 1.031486033
Sector Monitoring 2012 | National Blood Authority /sector-monitoring-2012 62280 916 1.033369137
Sector Monitoring 2013 | National Blood Authority /sector-monitoring-2013 64556 959 0.918449334
Sector Monitoring 2014 | National Blood Authority /sector-monitoring-2014 64073 954 0.967848649
Sector Monitoring 2015 | National Blood Authority /sector-monitoring-2015 65174 975 0.940563461
Sector Performance Indicators | National Blood Authority /sector-performance-indicators 62316 1226 0.809474363
Single Unit Transfusion Guide | National Blood Authority /single-unit-transfusion 65613 1288 1.024545957
Single Unit Transfusion Guide | National Blood Authority /single-unit-transfusion-guide 56648 845 0.838191587
Small volume tubes at Flinders Medical Centre, SA | National Blood Authority /small-volume-tubes-flinders-medical-centre-sa 66084 1143 1.095119702
2. Speed of Release | National Blood Authority /Speed-of-Release 68250 1329
2. Staffing and governance | National Blood Authority /staffing-and-governance 67270 1204 1.497423808
Standard 7 and the Patient Blood Management (PBM) Guidelines | National Blood Authority /standard-7-and-patient-blood-management-pbm-guidelines 62480 1000 2.784311367
Standard 7 Review | National Blood Authority /standard-7-review 62657 1157 1.673552936
National Stewardship Program | National Blood Authority /stewardship 62909 1165 1.395659381
Stop the Waste! | National Blood Authority /stopthewaste 63820 1037 1.60045862
Stop the Waste! Promotional Material Order Form | National Blood Authority /stopthewaste/orderform 84468 964 1.162136828
Stop the Waste Promotional Material | National Blood Authority /stop-waste-promotional-material 63801 1055 1.463264448
Stop the Waste! - promotional material now available online | National Blood Authority /stop-waste-promotional-material-now-available-online 57046 865 0.919408352
1. Strong Inventory Management and Control | National Blood Authority /strong-inventory-management 74755 2058 0.192832229
Subcutaneous immunoglobulin governing arrangements now available for hospitals | National Blood Authority /subcutaneous-immunoglobulin-governing-arrangements-now-available-hospitals 57106 813 0.972994549
Subcutaneous immunoglobulin (SCIg) approved for ordering now | National Blood Authority /subcutaneous-immunoglobulin-scig-approved-ordering-now 57255 879 0.971964647
Customer Feedback on Commercial Supply Contracts | National Blood Authority /supplier-feedback 64002 1292 1.597027743
Suppliers Update - 20 June 2013 | National Blood Authority /suppliers-update-20-june-2013 56632 846 0.889780857
Suppliers Update presentations now available | National Blood Authority /suppliers-update-presentations-now-available 56696 829 0.875289579
Supply Arrangements for Imported Plasma and Recombinant Products | National Blood Authority /supply-arrangements-imported-plasma-and-recombinant-products 56939 822 0.964325689
Supply to Australians Overseas | National Blood Authority /supply-australians-overseas 66712 1471 1.705061483
Supply Planning and Management | National Blood Authority /supply-planning 65423 1582 1.515541269
Supply Risk Management Measures | National Blood Authority /supply-risk-management-measures 66837 1689 1.623496196
/system/files/14523_NBA%20Module%206%20Neonat_Paediatrics_internals_5_FA_updated_15Feb2017.pdf 18572063 0 0.685153052
/system/files/14585_NBA_Module_6_QRG_UPDATED%20PDF_10May17.pdf 10589974 0 1.65822727
/system/files/2014-15-eoy-purchases.pdf 93049 0 0.690489518
/system/files/2014-15-eoy-purchases.xlsx 16778 248 0.812520934
/system/files/2015-16-eoy-purchases_0.xlsx 17820 308 1.426409341
/system/files/2015-16-eoy-purchases.pdf 93822 0 0.718676128
/system/files/2015-session-3-5-maureen-jacobson-blood-on-board-consent-yes.pdf 978397 0 0.925473661
/system/files/2015-session3-7-lisa-mansini-and-priscilla-moreira-the-changing-face-of-donor-phenotyping-at-the-blood-service.pdf 1857933 0 1.174242881
/system/files/2016-immunoglobulin-governance-national-policy-website.pdf 3487757 0 1.339042296
/system/files/abdr-annual-report-2015-16-final.docx 2927341 50785 0.868852337
/system/files/abdr-annual-report-2015-16-final.pdf 1360019 0 0.755864276
/system/files/Acquired-haemophilias-and-congenital-haemophilia-with-inhibitors2017.docx 55667 1036 0.734178814
/system/files/Acquired-haemophilias-and-congenital-haemophilia-with-inhibitors2017.pdf 444600 0 0.812845578
/system/files/Acute-leukaemia2017.docx 47820 839 0.749681958
/system/files/Acute-leukaemia2017.pdf 384701 0 0.718061869
/system/files/Adaptation-of-the-criteria-for-BloodSTAR2.docx 293419 3305 1.103289335
/system/files/Adaptation-of-the-criteria-for-BloodSTAR2.pdf 248089 0 1.324964737
/system/files/Anti-neutrophil-cytoplasmic-antibody%28ANCA%292017.docx 67408 1239 0.664194938
/system/files/Anti-neutrophil-cytoplasmic-antibody%28ANCA%292017.pdf 453996 0 0.668725579
/system/files/aust-haemovigilance-min-data-set.docx 961710 13276 0.776910951
/system/files/aust-haemovigilance-min-data-set.pdf 2250690 0 1.101715802
/system/files/Australian-Haemovigilance-Report-2016.docx 6401223 118542 1.040361282
/system/files/Australian-Haemovigilance-Report-2016.pdf 1537671 0 0.768654629
/system/files/Autoimmune-congenital-heart-block2017.docx 57121 1078 0.664000831
/system/files/Autoimmune-congenital-heart-block2017.pdf 429511 0 0.759125081
/system/files/Autoimmune-encephalitis-mediated-by-antibodies-targeting-cell-surface-antigens%28AMAE%292017.docx 77001 1352 0.77295063
/system/files/Autoimmune-encephalitis-mediated-by-antibodies-targeting-cell-surface-antigens%28AMAE%292017.PDF 488903 0 0.782396061
/system/files/Autoimmune-neutropenia2017.docx 53023 958 0.737708635
/system/files/Autoimmune-neutropenia2017.pdf 423709 0 0.792737635
/system/files/Autoimmune-retinopathy%28previously-Autoimmune-uveitis%292017.pdf 423975 0 0.689620637
/system/files/BloodNet%20Authorisations%20-%20Dispensing%20from%20an%20in-system%20request.docx 542358 9662 0.837557817
/system/files/BloodNet%20Authorisations%20-%20Dispensing%20from%20an%20in-system%20request.pdf 345873 0 0.659670153
/system/files/BloodNet%20Authorisations%20-%20Dispensing%20from%20an%20out-of-system%20request.docx 480846 8669 0.65061581
/system/files/BloodNet%20Authorisations%20-%20Dispensing%20from%20an%20out-of-system%20request.pdf 286448 0 0.728353847
/system/files/BloodNet%20Authorisations%20-%20Ordering%20Immunoglobulin.docx 394562 6653 0.927700905
/system/files/BloodNet%20Authorisations%20-%20Ordering%20Immunoglobulin.pdf 279645 0 0.99011369
/system/files/BloodNet-News-June-2016.pdf 441496 0 0.768996226
/system/files/BloodNet-Stock-Ordering-Tipsheet.docx 755657 15403 0.950880765
/system/files/BloodNet-Stock-Ordering-Tipsheet.pdf 772704 0 0.584768914
/system/files/Blood-Sector-Systems-Supported-Browsers-and-Devices.docx 79642 1213 1.02413897
/system/files/Blood-Sector-Systems-Supported-Browsers-and-Devices.pdf 146280 0 1.390234287
/system/files/BloodSTAR%20Newsletter%20-%20May%202016.docx 59444 1167 0.734900422
/system/files/BloodSTAR%20Newsletter%20-%20May%202016.pdf 458578 0 0.826790578
/system/files/BloodSTAR%20Tip%20Sheet%20-%20Return%20to%20Stock%20Episode.docx 900749 18149 0.58848366
/system/files/BloodSTAR%20Tip%20Sheet%20-%20Return%20to%20Stock%20Episode.pdf 432736 0 0.842398098
/system/files/BloodSTAR%20Tip%20Sheet%20-%20Submitting%20an%20Ig%20dispense%20request%20for%20a%20patient%20from%20another%20facility%20or%20state%20-%20the%20travelling%20patient.pdf 650475 0 0.55291092
/system/files/BloodSTAR%E2%80%93Medical-Officer-Notifications-Page.docx 349556 5688 0.686630249
/system/files/BloodSTAR%E2%80%93Medical-Officer-Notifications-Page.pdf 411935 0 0.861223557
/system/files/BloodSTAR-Medical-Officer-Home-Page.docx 351592 5826 0.731355984
/system/files/BloodSTAR-Medical-Officer-Home-Page.pdf 753828 0 1.061118847
/system/files/BloodSTAR-Newsletter-April-2016.docx 140070 2681 0.775938341
/system/files/BloodSTAR-Newsletter-April2016.pdf 280221 0 1.093197619
/system/files/BloodSTAR-Newsletter-August2016.pdf 128472 0 1.105947023
/system/files/BloodSTAR-Newsletter-December-2016.pdf 172003 0 0.786736505
/system/files/BloodSTAR-Newsletter-February-2017.pdf 149992 0 1.316722338
/system/files/BloodSTAR-Newsletter-June-2016.docx 59608 1134 0.863161252
/system/files/BloodSTAR-Newsletter-November-2016.pdf 262959 0 0.731753473
/system/files/BloodSTAR-Newsletter-October-2017.pdf 464147 0 1.346524622
/system/files/BloodSTAR-Product-or-Dose-Change-Request.docx 438161 7458 0.69547121
/system/files/BloodSTAR-Product-or-Dose-Change-Request.pdf 721264 0 0.767513641
/system/files/BloodSTAR-Submitting-Immunoglobulin-Authorisation-Requests-While-Access-to-your-Facility-is-Pending.docx 403666 6671 0.707782163
/system/files/BloodSTAR-Submitting-Immunoglobulin-Authorisation-Requests-While-Access-to-your-Facility-is-Pending.pdf 304419 0 0.778835313
/system/files/BloodSTAR-SubmittingReviewOutcomesandCreatingaContinuingAuthorisationRequest.docx 448543 7460 0.727467192
/system/files/BloodSTAR-SubmittingReviewOutcomesandCreatingaContinuingAuthorisationRequest.pdf 330941 0 0.746811794
/system/files/BloodSTAR-Tip-Sheet-Changing-Between-Roles.docx 480937 7806 0.577724114
/system/files/BloodSTAR-Tip-Sheet-Changing-Between-Roles.pdf 274463 0 0.7388707
/system/files/BloodSTAR-Tip-Sheet-Providing-Access-to-Facility-Administrators.docx 306836 4603 0.730277367
/system/files/BloodSTAR-Tip-Sheet-Providing-Access-to-Facility-Administrators.pdf 224277 0 0.716586668
/system/files/BloodSTAR-Tip-Sheet-Requesting-an-Authorisation-Under-a-New-Condition.docx 972560 18509 0.670889108
/system/files/BloodSTAR-Tip-Sheet-Requesting-an-Authorisation-Under-a-New-Condition.pdf 637836 0 0.719650216
/system/files/BloodSTAR-Tip-Sheet-SCIg-Dispensers.docx 419728 6705 0.754912407
/system/files/BloodSTAR-Tip-Sheet-SCIg-Dispensers.pdf 231971 0 0.781175001
/system/files/BloodSTAR-Tip-Sheet-SCIg-Nurses.docx 693642 12823 0.78319913
/system/files/BloodSTAR-Tip-Sheet-SCIg-Nurses.pdf 444141 0 0.850578105
/system/files/BloodSTAR-Tip-Sheet-SCIg-Prescribers.docx 316739 4876 0.63297729
/system/files/BloodSTAR-Tip-Sheet-SCIg-Prescribers.pdf 233095 0 0.877056931
/system/files/BloodSTAR-Tip-Sheet-Transfer-of-care.docx 1060033 19390 0.720824168
/system/files/BloodSTAR-Tip-Sheet-Transfer-of-care.pdf 861306 0 0.623845745
/system/files/BloodSTAR-User-Tip-Sheet-Dispense-discrepancies-and-unmatched-fate-episodes.docx 708994 12642 0.642249349
/system/files/BloodSTAR-User-Tip-Sheet-Dispense-discrepancies-and-unmatched-fate-episodes.pdf 425829 0 0.625809464
/system/files/BloodSTAR-User-Tip-Sheet-Registration%20-and-Role-Requests.docx 789605 14785 1.088336944
/system/files/BloodSTAR-User-Tip-Sheet-Registration%20-and-Role-Requests.pdf 554841 0 0.802398836
/system/files/BloodSTAR-User-Tip-Sheet-Reviewing-User-Access-Requests.docx 415906 6343 1.373637366
/system/files/BloodSTAR-User-Tip-Sheet-Reviewing-User-Access-Requests.pdf 336222 0 1.3101575
/system/files/Catastrophic-anti-phospholipid-syndrome2017.docx 60921 1114 0.640006499
/system/files/Catastrophic-anti-phospholipid-syndrome2017.pdf 419148 0 0.79478687
/system/files/Childhood-epileptic-encephalopathy%28previously-known-as-Epilepsy%292017.docx 53462 885 0.710056414
/system/files/Childhood-epileptic-encephalopathy%28previously-known-as-Epilepsy%292017.pdf 446740 0 0.952754947
/system/files/Clinical-indications-for-Apheresis-and-Whole-Blood-Platelets.docx 507586 8744 1.084197442
/system/files/Clinical-indications-for-Apheresis-and-Whole-Blood-Platelets.pdf 313879 0 1.316665444
/system/files/contact-details-normal-human-immunoglobulin-%28nhig%29-order-formv1.1_1.docx 55816 1098 1.067695847
/system/files/contact-details-normal-human-immunoglobulin-%28nhig%29-order-formv1.1_1.pdf 201441 0 1.300121738
/system/files/Data-Breach-Response-Plan_0.pdf 674558 0 0.7056742
/system/files/Data-Breach-Response-Plan.docx 1055841 13695 1.016822843
/system/files/Deed-of-Agreement.pdf 827265 0 1.152697662
/system/files/Development-of-the-Criteria-First-Edition.docx 305447 3541 0.630480044
/system/files/Development-of-the-Criteria-First-Edition.pdf 367557 0 1.132179127
/system/files/Development-of-the-Criteria-Second-Edition2.docx 305683 3525 0.768706275
/system/files/Development-of-the-Criteria-Second-Edition2.pdf 227030 0 0.769118148
/system/files/Diabetic-amyotrophy2017.docx 47853 783 0.634717154
/system/files/Diabetic-amyotrophy2017.pdf 396587 0 0.867775619
/system/files/documents/2008-session-2-speaker-5-mark-burton-platelet-alloantibody-testing.PDF 99192 0 0.671669735
/system/files/documents/2008-session-2-speaker-6-pam-hudson-case-report.PDF 398745 0 0.776372095
/system/files/documents/2008-session-3-speaker-2-geoff-magrin-lightning-strikes-twice_1.PDF 455527 0 0.773730469
/system/files/documents/2008-session-4-speaker-6-carolyn-duck-a-hot-blood-topic.PDF 325653 0 0.716233213
/system/files/documents/2008-session-4-speaker-7-sarah-eccles-body-of-data.PDF 274002 0 0.681576251
/system/files/documents/2008-session-5-speaker-2-robyn-turner-to-b-or-not-to-b.PDF 81406 0 0.748319855
/system/files/documents/2008-session-5-speaker-3-tony-greenfield-wrong-blood-in-tube.PDF 826944 0 0.753955616
/system/files/documents/2008-session-5-speaker-4-jo-cameron-and-olivia-house-his-past-comes-back-to-haunt-him.PDF 534875 0 0.711316315
/system/files/documents/2008-session-5-speaker-5-betty-huang-anti-jk3.PDF 2288146 0 0.698615254
/system/files/documents/2008-session-6-speaker-3-pauline-hinks-review-of-obstetric-haemorrhage.PDF 474074 0 0.736509794
/system/files/documents/2008-session-6-speaker-4-mary-comande-emergency-blood-supply-contingency.PDF 899691 0 0.664692207
/system/files/documents/2009-session-1-speaker-8-sarah-eccles-whats-in-a-name.PDF 89383 0 0.709866368
/system/files/documents/2009-session-1-speaker-9-cathy-hughes-where-the-titre-are-we-going.PDF 786379 0 0.6416708
/system/files/documents/2009-session-2-speaker-5-jo-micallef-what-exactly-is-her-phenotype_0.PDF 207925 0 0.723424709
/system/files/documents/2009-session-3-speaker-4-anne-marie-wilkes-anti-g.PDF 117545 0 0.702853371
/system/files/documents/2009-session-4-speaker-1-tony-greenfield-massive-transfusion-with-h1n1-influenza.pdf 1701234 0 0.757477886
/system/files/documents/2009-session-4-speaker-3-pauline-hinks-twas-wright-eh.pdf 828300 0 0.716891923
/system/files/documents/2009-session-4-speaker-5-sue-finch-secret-antibody-business.pdf 1660090 0 0.724704729
/system/files/documents/2009-session-5-speaker-1-kelly-sliwinski-apples-in-disguise.pdf 75121 0 0.607257546
/system/files/documents/2009-session-5-speaker-2-hayley-keenan-abo-discrepancy.pdf 116704 0 0.693045564
/system/files/documents/20110606-media-release-iprp-tender_0.docx 47059 902 0.737716634
/system/files/documents/20110606-media-release-iprp-tender_0.pdf 180210 0 0.830776451
/system/files/documents/20111019-media-release-imported-ivig_0.docx 54664 1036 0.742379832
/system/files/documents/20111019-media-release-imported-ivig_0.pdf 147927 0 0.701807246
/system/files/documents/20120808-media-release-bloodnet-berri_0.docx 38669 746 0.736337337
/system/files/documents/20120808-media-release-bloodnet-berri_0.pdf 208724 0 0.685147266
/system/files/documents/20120810-media-release-partnerships-ivig_0.docx 41394 784 1.161213009
/system/files/documents/20120810-media-release-partnerships-ivig_0.pdf 257356 0 0.782867147
/system/files/documents/20120917-media-release-pbm-launch_0.docx 37549 676 1.007058548
/system/files/documents/20120917-media-release-pbm-launch_0.pdf 125544 0 0.604924792
/system/files/documents/2013-14-blood-service-performance-report-to-coag.pdf 156011 0 0.64806039
/system/files/documents/2013-14-eoy-purchases_0.pdf 92789 0 0.69809098
/system/files/documents/2013-14-eoy-purchases.xlsx 16366 259 1.070389164
/system/files/documents/2013-16-statement-of-expectations.doc 130560 0 0.651404813
/system/files/documents/2013-16-statement-of-expectations.pdf 76743 0 0.698845383
/system/files/documents/2014-session-1-1-bronywn-prescott-anti-rg.pdf 693716 0 0.500884495
/system/files/documents/2014-session-1-3-helen-henry-kollection.pdf 556214 0 0.656708028
/system/files/documents/2014-session-1-4-kylie-rushford-anti-jmh.pdf 343382 0 0.617259859
/system/files/documents/2014-session-1-5-maria-svha2.pdf 593510 0 0.762185875
/system/files/documents/2014-session-1-6-nicole-williams-nokidding.pdf 1063084 0 0.809543735
/system/files/documents/2014-session-1-7-orhan-sheriff-home-time.pdf 2368791 0 0.808069721
/system/files/documents/2014-session-1-8-trish-fiddy-jra-handle-with-care.pdf 654109 0 0.663581572
/system/files/documents/2014-session-2-1-billy-vincent-sickle-me-ecmo.pdf 824382 0 0.755478636
/system/files/documents/2014-session-2-2-britt-coelho-anti-k-2.pdf 1587245 0 0.613926743
/system/files/documents/2014-session-2-3-helen-bardsley-ttts.pdf 1284644 0 0.599383028
/system/files/documents/2014-session-2-4-nicole-filipinski-the-bbq-from-hell.pdf 1142964 0 0.771717965
/system/files/documents/2014-session-2-5-alison-boyd-and-sue-quiring-whats-a-bruise-cost2.pdf 746544 0 0.743960164
/system/files/documents/2014-session-2-6-rhonda-hosken-trali-an-acute-transfusion-reaction-that-con.pdf 394682 0 0.746819179
/system/files/documents/2014-session-2-7-sam-lennard-anaemia-in-neonate.pdf 117737 0 0.666803547
/system/files/documents/2014-session-2-8-sudhir-berry-more-than-meets-the-eye.pdf 208131 0 0.617782714
/system/files/documents/2014-session-3-1-jo-cameron-fridges.pdf 1687047 0 0.63437223
/system/files/documents/2014-session-3-2-marianne-de-souza-mtp-at-canberra.pdf 690421 0 0.719384965
/system/files/documents/2014-session-3-3-muni-swastika-naicker-logistics.pdf 922756 0 0.758959303
/system/files/documents/2014-session-3-4-nadine-verdoorn-lean-labs.pdf 423770 0 0.735450096
/system/files/documents/2014-session-3-5-natalie-stewart-gazing-into-the-crysta-bBall.pdf 423077 0 0.723616482
/system/files/documents/2014-session-3-6-petra-chitsaka-myabdr.pdf 1857439 0 0.585184698
/system/files/documents/2014-session-3-7-steven-lamb-blood-down-the-drain.pdf 708243 0 0.755215932
/system/files/documents/2014-session-3-8-vaughan-davies-supporting-the-national-blood-wastage-reduction-strategy.pdf 1526710 0 0.816351081
/system/files/documents/2014-session-4-1-kat-chimerism.pdf 532039 0 0.563434337
/system/files/documents/2014-session-4-2-priscilla-moreira-and-lisa-masini-manual-bench-detective-work.pdf 1265399 0 0.706156642
/system/files/documents/2014-session-4-3-hamed-mohammadi-and-uwen-walker-liver-transplant-anti-yta.pdf 518246 0 0.586976088
/system/files/documents/2014-session-4-4-gayathri-silva-and-judy-cheng-blood-group-discrepancies.pdf 555539 0 0.633270204
/system/files/documents/2014-session-5-1-aaron-keenan-anti-d-ig.pdf 410371 0 0.741307414
/system/files/documents/2014-session-5-2-french-pugh-van-der-molen-artificial-blood.pdf 623253 0 0.596922144
/system/files/documents/2014-session-5-3-melanie-mcmahon-future-of-neonatal-rh-testing.pdf 1070585 0 0.727200123
/system/files/documents/2014-session-5-4a-wikes-titration-pools.pdf 1198186 0 0.698744375
/system/files/documents/2014-session-5-5-avril-wentworth-aiha.pdf 1386938 0 0.595619307
/system/files/documents/2014-session-6-2-sarah-eccles-sounds-like-an-antibody.pdf 414539 0 0.75514828
/system/files/documents/2014-session-6-3-pauline-hinks-aiha-or-something-else.pdf 2519316 0 0.691867315
/system/files/documents/2014-session-6-4-madeleine-price-is-this-a-transfusion-reaction2.pdf 834507 0 0.635403798
/system/files/documents/2014-session-6-5-tony-greenfield-the-rfid-blood-fridge-one-year-on2.pdf 1126265 0 1.085972659
/system/files/documents/2015-session-1-1-bronwyn-prescott-rbc-alloimmunisation-post-platelet-transfusion-consent-yes_5.pdf 1329849 0 0.79478475
/system/files/documents/2015-session-1-3-kylie-rushford-haemolytic-disease-of-the-newborn-due-to-a-low-incidence-antigen-consent-yes.pdf 923783 0 1.043225722
/system/files/documents/2015-session-1-5-carmen-hooley-jackie-daley-helloe-is-it-d-youre-looking-for-consent-yes_0.pdf 384805 0 1.068479508
/system/files/documents/2015-session-1-9-paul-barankewitsch-red-cell-alloantibody-frequency-in-a-western-australian-population-consent-yes_1.pdf 1167726 0 0.647334899
/system/files/documents/2015-session-2-3-claire-grattidge-power-tools-in-the-immunohaematology-toolbox-consent-yes_2.pdf 157405 0 0.614519037
/system/files/documents/2015-session-2-6-christine-irving-can-origin-of-anti-d-be-determined-using-serological-methods-consent-yes.pdf 84240 0 1.040743471
/system/files/documents/2015-session-2-7-lina-holmquist-a-case-of-good-luck-and-good-practice-consent-yes.pdf 826167 0 0.696102881
/system/files/documents/2015-session-3-10-rebecca-heland-dont-panic-bloodstar-is-here-consent-yes.pdf 1621180 0 0.89263049
/system/files/documents/2015-session3-1-alison-badger-preparing-for-the-games-consent-yes.pdf 344100 0 0.766476656
/system/files/documents/2015-session-3-2-jo-cameron-a-cool-development-for-bloodnet-consent-yes_0.pdf 2187080 0 0.744340021
/system/files/documents/2015-session-3-3-kate-jongschaap-logistical-nightmare-ivig-in-tasmania-consent-yes.pdf 3384523 0 0.567613424
/system/files/documents/2015-session-3-4-kelly-sliwinski-goldielocks-and-the-three-bears-consent-yes.pdf 1384405 0 0.750944616
/system/files/documents/2015-session-3-8-ken-nollet-transfusion-under-triple-threat-japans-earthquake-tsunami-and-nuclear-crisis-session-consent-yes_0.pdf 6890626 0 0.585021957
/system/files/documents/2015-session-4-1-clameo-chimfombo-a-blood-group-discrepancy-involving-ant-m-in-pregnancy-consent-yes.pdf 106646 0 0.725736707
/system/files/documents/2015-session-4-3-kelly-whettingsteel-abo-and-rhd-chimerism-if-you-leave-me-can-i-come-too-consent-yes.pdf 267076 0 0.652998833
/system/files/documents/2015-session-4-4-scott-nichols-and-billy-vincent-a-collaborative-approach-to-pbm-blood-bank-perspective-consent-yes-both.pdf 3478826 0 0.817529053
/system/files/documents/2015-session-4-5-sarah-eccles-blood-loss-estimates-in-obstetric-haemorrhage-consent-yes.pdf 394536 0 0.743426269
/system/files/documents/2015-session-4-6-dot-stern-visual-assessment-of-simulated-post-partum-haemorrhage-consent-yes.pdf 9781391 0 0.835067637
/system/files/documents/2015-session-4-7-michaela-sison-massive-transfusion-protocol-at-royal-darwin-hospital-consent-yes.pdf 1916777 0 0.597011057
/system/files/documents/2015-session-5-2-hannah-black-developing-and-testing-the-specificity-of-antibody-mixtures-for-transfusion-science-practical-classes-consent-yes.pdf 103403 0 0.784316432
/system/files/documents/2015-session-5-6-amanda-wiley-a-rare-anti-inb-consent-yes_0.pdf 515209 0 1.036787803
/system/files/documents/2015-session-5-7-lachlan-meng-all-we-hear-is-radio-frequency-identification-consent-yes.pdf 1509697 0 0.68485
/system/files/documents/2015-session-6-1-max-keogh-blood-product-management-in-regional-laboratories-consent-yes.pdf 293515 0 0.8118149
/system/files/documents/2015-session-6-6-rebecca-davidson-ivig-in-hdfn-consent-yes.pdf 1238631 0 1.244640239
/system/files/documents/2016-immunoglobulin-governance-national-policy-updatev4_cover_father_son_2.pdf 3834957 0 1.075949745
/system/files/documents/2016-immunoglobulin-governance-national-policy-updatev4.docx 8003085 139214 0.718776788
/system/files/documents/20171108-PBM-Module3.pdf 954952 0 1.141216844
/system/files/documents/2-blood-fridge-maintenance-pdf.pdf 66116 0 0.852981329
/system/files/documents/%5BFinal%5D%20Point%20of%20Care%20Coagulation%20Testing%20Case%20Study.pdf 4703346 0 0.985078974
/system/files/documents/aaron-keenan-and-jason-de-castro-a-case-study-on-the-use-of-fibringen-concentrate-2013-session-1-speaker-5.pdf 1502510 0 0.772188863
/system/files/documents/ABDR%20and%20privacy%20consent%20consumer%20information%20leaflet.doc 542208 0 0.713358055
/system/files/documents/ABDR_and_privacy_consent_consumer_information_leaflet.doc 542208 0 0.89408878
/system/files/documents/ABDR_and_privacy_consent_consumer_information_leaflet.pdf 257920 0 0.637393044
/system/files/documents/abdr-annual-report-2011-12-20140423.docx 2596367 42014 0.722036119
/system/files/documents/abdr-annual-report-2011-12-20140423.pdf 1870001 0 1.169947137
/system/files/documents/abdr-annual-report-2012-13-V5-20140423_0.docx 2951561 49519 0.699558265
/system/files/documents/abdr-annual-report-2012-13-V5-20140423.pdf 2109249 0 0.776247283
/system/files/documents/abdr-annual-report-2014-15-final.docx 2130349 34872 1.02173194
/system/files/documents/abdr-annual-report-2014-15-final.pdf 1442922 0 0.753980325
/system/files/documents/abdr-myabdr-privacy-collection-notice-and-consent-form.docx 198030 3690 0.638939799
/system/files/documents/abdr-myabdr-privacy-collection-notice-and-consent-form.pdf 80992 0 0.57182237
/system/files/documents/abdr-myabdr-privacy-collection-notice-consent-form-with-pseudonym.docx 153794 2812 0.677799933
/system/files/documents/abdr-myabdr-privacy-collection-notice-consent-form-with-pseudonym.pdf 93644 0 0.724306196
/system/files/documents/abdr-myabdr-privacy-collection-notice-with-id-space.docx 153795 2779 1.156144636
/system/files/documents/abdr-myabdr-privacy-collection-notice-with-id-space.pdf 93394 0 0.567219959
/system/files/documents/abdr-myabdr-privacy-consent-points-for-use-pseudonym_0.pdf 77034 0 0.758010453
/system/files/documents/abdr-myabdr-privacy-consent-points-for-use-pseudonym.docx 194348 3588 0.751648133
/system/files/documents/abdr-myabdr-privacy-consent-step-by-step-guide-mobile-app.docx 3059660 56059 0.597721874
/system/files/documents/abdr-myabdr-privacy-consent-step-by-step-guide-mobile-app.pdf 1530760 0 0.71995989
/system/files/documents/abdr-myabdr-privacy-consent-step-by-step-guide-web-app.docx 3648818 60623 0.669945699
/system/files/documents/abdr-myabdr-privacy-consent-step-by-step-guide-web-app.pdf 1659833 0 0.996062462
/system/files/documents/abdr-myabdr-privacy-consent-verbal-consent-scriptform-v2-140115.docx 24503 410 0.779380643
/system/files/documents/abdr-myabdr-privacy-consent-verbal-consent-scriptform-v2-140115.pdf 88395 0 0.831400153
/system/files/documents/abdr-myabdr-privacy-policy-v1.docx 1475979 24503 1.01225072
/system/files/documents/abdr-myabdr-privacy-policy-v1.pdf 366115 0 1.256108111
/system/files/documents/abdr-patient-pamphlet.pdf 1349501 0 0.797206421
/system/files/documents/abdr-sc-annual-reports-final_0.pdf 2121476 0 0.750750682
/system/files/documents/abdr-sc-annual-reports-final.docx 2853502 46961 1.78565787
/system/files/documents/acorn-autumn-2014-pbm-for-perioperative-setting.pdf 32433 0 2.372581234
/system/files/documents/acute-disseminated-encephalomyelitis%28adem%29.DOCX 46898 787 0.90605806
/system/files/documents/acute-disseminated-encephalomyelitis%28adem%29.PDF 171883 0 0.808470022
/system/files/documents/adbr-myabdr-consent-to-privacy-leaflet.pdf 370318 0 0.748359735
/system/files/documents/addendum-to-abdr-annual-report-2015-16.docx 24801 352 0.710274507
/system/files/documents/addendum-to-abdr-annual-report-2015-16.pdf 63139 0 0.780907622
/system/files/documents/addie-steele-chimera-2011-session-4-speaker-1.pdf 209763 0 0.836162932
/system/files/documents/amendment-national-blood-agreement.pdf 106675 0 1.148512684
/system/files/documents/anastasia-osadchuk-the-diego-adventure-2013-session-3-speaker-6.pdf 2867973 0 1.104132854
/system/files/documents/anne-marie-wilkes-reducing-the-waste-2013-session-4-speaker-3.pdf 3450105 0 0.60832154
/system/files/documents/anne-marie-wilkes-severe-aneamia-in-a-newborn-2011-session-4-speaker-2.pdf 813296 0 0.613229132
/system/files/documents/anne-marie-wilkes-the-role-of-plasmapheresis-in-the-treatment-of-severe-rhd-iso-immunisation-2010-session-2-speaker-5.PDF 247064 0 0.73026585
/system/files/documents/anti-neutrophil-cytoplasmic-antibody%28anca%29.DOCX 61885 1138 0.724654467
/system/files/documents/anti-neutrophil-cytoplasmic-antibody%28anca%29.PDF 156299 0 0.72557018
/system/files/documents/appendix-1-example-clinical-guideline-format-single-unit-transfusion.doc 183296 0 2.540292928
/system/files/documents/appendix-1-from-iron-product-choice-and-dose-calculation04082015.pdf 59317 0 1.913273238
/system/files/documents/Appendix1-IPRP-Potential-Future-Arrangements-Summary-Responses.docx 53367 910 1.337622103
/system/files/documents/Appendix1-IPRP-Potential-Future-Arrangements-Summary-Responses.pdf 91301 0 0.812418463
/system/files/documents/appendix-1-iron-product-choice-and-dose-calculation-adults-v2_0.docx 43961 754 4.406349489
/system/files/documents/appendix-1-transfer-establishment-and-review-checklist.docx 23410 363 0.714184526
/system/files/documents/appendix-1-transfer-establishment-and-review-checklist.pdf 79377 0 0.661793449
/system/files/documents/Appendix2-Assessment-Extended-Half-Life-Clotting-Factor-Concentrates.docx 396596 5579 1.093974771
/system/files/documents/Appendix2-Assessment-Extended-Half-Life-Clotting-Factor-Concentrates.pdf 541994 0 1.068041437
/system/files/documents/appendix-2-example-validation-plan.docx 1625482 30191 0.642922281
/system/files/documents/appendix-2-example-validation-plan.pdf 183783 0 0.698125476
/system/files/documents/appendix-2-from-iron-product-choice-and-dose-calculation04082015.pdf 29048 0 0.826145208
/system/files/documents/appendix-2-implementation-guide-single-unit-transfusion.pdf 140686 0 0.88389293
/system/files/documents/appendix-2-iron-product-choice-and-dose-calculation-adults-v2.docx 43526 704 0.827982135
/system/files/documents/appendix-3%20-example-memorandum-of-understanding.docx 36039 658 1.078760535
/system/files/documents/appendix-3%20-example-memorandum-of-understanding.pdf 117273 0 0.788758124
/system/files/documents/appendix-3-example-handout-single-unit-transfusion.docx 40995 733 0.739270583
/system/files/documents/appendix-3-example-handout-single-unit-transfusion.pdf 112587 0 0.71145746
/system/files/documents/appendix-3-from-iron-product-choice-and-dose-calculation20052016.pdf 160053 0 0.740038757
/system/files/documents/appendix-3-iron-product-choice-and-dose-calculation-adults20052016.docx 449761 8388 0.705036479
/system/files/documents/appendix-4-example-powerpoint-presentation-single-unit-transfusion.pdf 121760 0 0.80317241
/system/files/documents/appendix-4-example-powerpoint-presentation-single-unit-transfusion.pptx 2464709 48056 0.769433061
/system/files/documents/appendix-4-transfer-procedure-checklist.docx 26286 390 0.706679826
/system/files/documents/appendix-4-transfer-procedure-checklist.pdf 79710 0 0.590968264
/system/files/documents/appendix-5-blood-fridge-maintenance-record.docx 44612 743 0.653264238
/system/files/documents/appendix-5-blood-fridge-maintenance-record.pdf 72301 0 0.729731081
/system/files/documents/appendix-5-example-newsletter-single-unit-transfusion.pdf 73393 0 1.17507504
/system/files/documents/appendix-6-blood-and-blood-product-transfer-form.docx 30097 564 0.75859213
/system/files/documents/appendix-6-blood-and-blood-product-transfer-form.pdf 117447 0 0.745899268
/system/files/documents/appendix-6-example-posters-single-unit-transfusion.docx 2775558 47988 1.064522389
/system/files/documents/appendix-6-example-posters-single-unit-transfusion.pdf 867280 0 3.296827294
/system/files/documents/appendix-7-shipper-packing-slip-blood-consignment-record.docx 34849 624 0.71643861
/system/files/documents/appendix-7-shipper-packing-slip-blood-consignment-record.pdf 119103 0 0.73503891
/system/files/documents/appendix-8-shipper-label.docx 28110 498 0.751606163
/system/files/documents/appendix-8-shipper-label.pdf 66913 0 0.686078199
/system/files/documents/appendixes-intraoperative-cell-salvage_0.docx 27622 476 0.634365991
/system/files/documents/appendixes-intraoperative-cell-salvage_0.pdf 33973 0 0.842983282
/system/files/documents/appendix-iia-intraoperative-cell-salvage_0.docx 27476 473 0.64433364
/system/files/documents/appendix-iia-intraoperative-cell-salvage_0.pdf 34943 0 0.755698564
/system/files/documents/appendix-iib-intraoperative-cell-salvage_0.pdf 53946 0 0.739887287
/system/files/documents/appendix-iib-intraoperative-cell-salvage.docx 31777 561 0.777600835
/system/files/documents/appendix-iii-intraoperative-cell-salvage_0.docx 33986 576 0.649072219
/system/files/documents/appendix-iii-intraoperative-cell-salvage_0.pdf 80562 0 0.695017886
/system/files/documents/appendix-i-intraoperative-cell-salvage_0.docx 114289 2130 0.759125927
/system/files/documents/appendix-i-intraoperative-cell-salvage_0.pdf 117244 0 0.703981064
/system/files/documents/appendix-iv-intraoperative-cell-salvage_0.pdf 119535 0 0.796615946
/system/files/documents/appendix-iv-intraoperative-cell-salvage.docx 148027 2891 0.727388196
/system/files/documents/appendix-ix-intraoperative-cell-salvage.docx 26465 480 0.715176818
/system/files/documents/appendix-ix-intraoperative-cell-salvage.pdf 39884 0 0.738932041
/system/files/documents/appendix-viii-intraoperative-cell-salvage_0.docx 24516 434 0.726869083
/system/files/documents/appendix-viii-intraoperative-cell-salvage.pdf 29555 0 0.750811824
/system/files/documents/appendix-vii-intraoperative-cell-salvage_0.docx 96420 1766 0.713334933
/system/files/documents/appendix-vii-intraoperative-cell-salvage.pdf 84223 0 0.690815015
/system/files/documents/appendix-vi-intraoperative-cell-salvage_0.docx 38150 664 0.716846054
/system/files/documents/appendix-vi-intraoperative-cell-salvage_0.pdf 51563 0 0.684925866
/system/files/documents/appendix-v-intraoperative-cell-salvage_0.docx 41385 767 0.732513549
/system/files/documents/appendix-v-intraoperative-cell-salvage_0.pdf 82819 0 0.702135167
/system/files/documents/appendix-xi-intraoperative-cell-salvage.docx 24600 412 0.672405533
/system/files/documents/appendix-xi-intraoperative-cell-salvage.pdf 29569 0 0.721777878
/system/files/documents/appendix-x-intraoperative-cell-salvage_0.docx 25792 400 0.715937657
/system/files/documents/appendix-x-intraoperative-cell-salvage_0.pdf 38464 0 0.796134864
/system/files/documents/att-c-mod5-tech-rep-vol1.pdf 2441243 0 0.572872252
/system/files/documents/att-d-mod5-tech-rep-vol2_0.pdf 3696435 0 0.876432926
/system/files/documents/australian-haemovigilance-report-2010_0.pdf 3288251 0 0.764376992
/system/files/documents/australian-treating-clinician-approval-form.doc 41472 0 0.657374083
/system/files/documents/autoimmune-encephalitis-mediated-by-antibodies-targeting-cell-surface-antigens_0.DOCX 51045 897 0.699421607
/system/files/documents/autoimmune-encephalitis-mediated-by-antibodies-targeting-cell-surface-antigens_0.PDF 159438 0 0.760598471
/system/files/documents/autoimmune-haemolytic-anaemia%28aiha%29.DOCX 67342 1200 0.647725494
/system/files/documents/autoimmune-haemolytic-anaemia%28aiha%29.PDF 189264 0 0.694065038
/system/files/documents/azadeh-zargari-issuing-rh-and-kell-compatible-blood-to-women-under-40-better-late-than-never-2012-session-4-speaker-4.pdf 178842 0 0.71211069
/system/files/documents/Better%20Practice%20Case%20Study%20%20BloodMove%20Platelets.pdf 1231716 0 2.839597926
/system/files/documents/better-practice-case-study-burnside-war-memorial-hospital-final-correction.pdf 1016797 0 1.081480994
/system/files/documents/better-practice-case-study-the-royal-childrens-hospital-melbourne-extended-life-plasma-protocol-updated-16-february-2016.pdf 278607 0 1.303746705
/system/files/documents/big-red-screenshot.png 372291 0 1.325960591
/system/files/documents/billy-vincent-pacemaker-leads-to-mtp-2013-session-1-speaker-3_0.pdf 3362223 0 0.627337901
/system/files/documents/billy-vincent-two-cases-of-rh-antibody-and-phenotype-%20discrepancies-2011-session-2-speaker-1.pdf 640058 0 0.776951537
/system/files/documents/BLOOD%20POSTER%201.pdf 808806 0 1.384647528
/system/files/documents/BLOOD%20POSTER_2.pdf 569067 0 0.875551043
/system/files/documents/BLOOD%20POSTER_3_0.pdf 51995 0 1.075027856
/system/files/documents/blood-and-blood-product-inventory-manual.pdf 330981 0 0.749038865
/system/files/documents/blood-fridge-checking-how-to-guide.pdf 528846 0 1.096406813
/system/files/documents/blood-fridgemaintenance-record-form-sample.pdf 257063 0 0.971859409
/system/files/documents/bloodmove-alarm-test.mp4 15698332 0 1.34735705
/system/files/documents/bloodmove-ashford.mp4 19926004 0 0.804031525
/system/files/documents/bloodmove-berri.mp4 20026129 0 1.058127201
/system/files/documents/bloodmove-berri-transport-and-storage.docx 21619 353 0.791024114
/system/files/documents/bloodmove-berri-transport-and-storage.pdf 59776 0 1.601431261
/system/files/documents/bloodmove-hub-spoke.gif 44196 0 0.721032911
/system/files/documents/bloodmove-kapunda.mp4 22181615 0 1.317710723
/system/files/documents/bloodmove-project-overview.mp4 102738621 0 0.920687974
/system/files/documents/bloodmove-red-cell-return-form.docx 23802 421 0.733918327
/system/files/documents/bloodmove-red-cell-return-form-pdf.pdf 25766 0 1.113277946
/system/files/documents/bloodmove-shipper.gif 45681 0 0.784870029
/system/files/documents/bloodmove-wastage_0.gif 76854 0 1.276553874
/system/files/documents/bloodmove-wastage-stewardship.mp4 57796173 0 1.247558906
/system/files/documents/BloodNet%20-%20Discard%20Tipsheet.docx 1144759 19609 0.666805223
/system/files/documents/BloodNet%20-%20Discard%20Tipsheet.pdf 834051 0 0.644298793
/system/files/documents/BloodNet%20-%20Transfer%20Tipsheet.docx 966039 14565 0.577980802
/system/files/documents/BloodNet%20-%20Transfer%20Tipsheet.pdf 339148 0 0.648097124
/system/files/documents/BloodNet-Authorisations-Checking-Patient-Authorisations.docx 521333 9319 1.106040759
/system/files/documents/BloodNet-Authorisations-Checking-Patient-Authorisations.pdf 979300 0 1.380310705
/system/files/documents/bloodnet-blood-fridges-module-flyer.docx 1002986 15593 1.082405326
/system/files/documents/bloodnet-blood-fridges-module-flyer.pdf 273368 0 0.855236015
/system/files/documents/bloodnet-facilityadmin-approval-tipsheet_0.docx 1095704 15356 0.7127134
/system/files/documents/bloodnet-facilityadmin-approval-tipsheet_1.pdf 518283 0 0.946482326
/system/files/documents/bloodnet-lis-interface-spec-3-3_1.docx 3576866 57576 1.15892352
/system/files/documents/bloodnet-lis-interface-spec-3-3_1.pdf 1977964 0 1.367742904
/system/files/documents/BloodNetReceiptingTipSheet.docx 599302 6745 0.78859421
/system/files/documents/BloodNetReceiptingTipSheet.pdf 548608 0 0.652133409
/system/files/documents/bloodnet-registration-tipsheet_0.docx 1389935 22384 0.604172807
/system/files/documents/bloodnet-registration-tipsheet_1.pdf 791502 0 0.654479904
/system/files/documents/BloodNet-Special-Ordering-Tipsheet.docx 368747 7152 0.6842947
/system/files/documents/BloodNet-Special-Ordering-Tipsheet.pdf 540520 0 0.577816358
/system/files/documents/BloodNet-User-Manualv25.1.docx 14301784 276182 1.332143532
/system/files/documents/BloodNet-User-Manualv25.1.pdf 9542183 0 1.310943367
/system/files/documents/blood-refrigerator-maintenance-record.docx 57478 1152 1.044286723
/system/files/documents/blood-refrigerator-temperature-chart.pdf 89878 0 0.857128813
/system/files/documents/blood-refrigerator-temperature-chart.sample.pdf 186334 0 0.582006641
/system/files/documents/blood-service-2012-13-performance-report.pdf 166766 0 0.692272689
/system/files/documents/BloodSTAR-Newsletter-July-2017.pdf 309742 0 1.175196981
/system/files/documents/BloodSTAR-Nurse-Home-Page-tip-sheet.docx 388423 6309 1.105216255
/system/files/documents/BloodSTAR-Nurse-Home-Page-tip-sheet.pdf 300943 0 1.106296198
/system/files/documents/BloodSTAR-recalling-resubmitting-authorisation-request.docx 431855 7508 0.665536107
/system/files/documents/BloodSTAR-recalling-resubmitting-authorisation-request.pdf 816781 0 0.898310644
/system/files/documents/BloodSTAR-Tip-Sheet-Creating-and-submitting-a-planning-sheet-in-BloodSTAR.docx 1056096 19787 0.663377304
/system/files/documents/BloodSTAR-Tip-Sheet-Creating-and-submitting-a-planning-sheet-in-BloodSTAR.pdf 794987 0 0.723397264
/system/files/documents/BloodSTAR-Tip-Sheet-Submitting-an-Ig-dispense-request-for-individual-patients-in-BloodSTAR.docx 465355 7566 0.769520345
/system/files/documents/BloodSTAR-Tip-Sheet-Submitting-an-Ig-dispense-request-for-individual-patients-in-BloodSTAR.pdf 266369 0 1.073207436
/system/files/documents/BloodSTAR-Tip-Sheet-Viewing-authorisation-details-in-BloodSTAR.docx 779091 13636 0.567523856
/system/files/documents/BloodSTAR-Tip-Sheet-Viewing-authorisation-details-in-BloodSTAR.pdf 450744 0 0.725505643
/system/files/documents/blood-supply-chain.png 54192 0 1.153302505
/system/files/documents/brendan-eager-what-the-f-2012-session-1-speaker-3.pdf 904676 0 0.732627508
/system/files/documents/bronwen-prescott-interesting-crossmatch-2012-session-1-speaker-6.pdf 532741 0 0.804320311
/system/files/documents/bullous-pemphigoid%28bp%29.DOCX 61534 928 0.685896391
/system/files/documents/bullous-pemphigoid%28bp%29.PDF 134368 0 0.818776159
/system/files/documents/carol-gofton-and-carly-brown-an-incompatible-crossmatch-2010-session-2-speaker-2.PDF 215593 0 0.665185192
/system/files/documents/carol-uellendahl-summary-of-high-titre-anti-ab-testing-at-the-blood-service-2010-session-3-speaker-3_0.PDF 227245 0 0.646527694
/system/files/documents/catherine-cockshott-should-we-call-it-mumbai-2010-session-2-speaker-3.PDF 784673 0 0.792045215
/system/files/documents/catherine-cockshott-supplying-the-wright-blood-anti-wra-2011-session-1-speaker-2.pdf 219082 0 0.584637101
/system/files/documents/cathy-hughes-history-of-the-rcpaqap-transfusion-programme-1969-to-2012-and-moves-to-the-future-2012-session-5-speaker-9_0.pdf 1010823 0 0.580978352
/system/files/documents/checklist-for-inventory-management-best-practice.docx 27586 461 0.983370295
/system/files/documents/checklist-for-inventory-management-best-practice.pdf 81200 0 1.496214747
/system/files/documents/chronic-inflammatory-demyelinating-polyneuropathy%28cidp%29.DOCX 66361 1219 0.777328307
/system/files/documents/chronic-inflammatory-demyelinating-polyneuropathy%28cidp%29.PDF 184616 0 1.313899152
/system/files/documents/chsalhn-blood-audit-tools-listing.pdf 176397 0 0.713617264
/system/files/documents/cicatricial-pemphigoid%28cp%29-or-mucous-membrane-pemphigoid%28mmp%29.DOCX 58954 944 0.889341502
/system/files/documents/cicatricial-pemphigoid%28cp%29-or-mucous-membrane-pemphigoid%28mmp%29.PDF 143185 0 0.681641203
/system/files/documents/companion-10-pbm-guidelines.docx 626852 10653 0.754757478
/system/files/documents/companion-10-pbm-guidelines.pdf 332809 0 0.585002976
/system/files/documents/companion-11-pbm-guidelines.docx 625356 10363 0.727505539
/system/files/documents/companion-11-pbm-guidelines.pdf 333233 0 0.668739533
/system/files/documents/companion-12-pbm-guidelines.docx 621636 10916 0.904655303
/system/files/documents/companion-12-pbm-guidelines.pdf 329328 0 1.045185148
/system/files/documents/companion-13-pbm-guidelines.pdf 329840 0 0.970508235
/system/files/documents/companion-14-pbm-guidelines.docx 624102 9967 0.651414592
/system/files/documents/companion-14-pbm-guidelines.pdf 329897 0 1.282287928
/system/files/documents/companion-15-pbm-guidelines.docx 626579 10478 0.751145025
/system/files/documents/companion-15-pbm-guidelines.pdf 332580 0 0.70944006
/system/files/documents/companion-16-pbm-guidelines.docx 624958 10557 0.74012437
/system/files/documents/companion-16-pbm-guidelines.pdf 331640 0 1.876449388
/system/files/documents/companion-17-pbm-guidelines.docx 625397 10457 0.919341384
/system/files/documents/companion-17-pbm-guidelines.pdf 330857 0 0.741259837
/system/files/documents/companion-18-pbm-guidelines.docx 627636 10379 2.060040625
/system/files/documents/companion-18-pbm-guidelines.pdf 333737 0 0.963028069
/system/files/documents/companion-19-pbm-guidelines.docx 618428 10198 0.806808762
/system/files/documents/companion-19-pbm-guidelines.pdf 330429 0 1.341298902
/system/files/documents/companion-1-pbm-guidelines_0.pdf 332677 0 1.209672113
/system/files/documents/companion-1-pbm-guidelines.docx 629659 10513 1.197851724
/system/files/documents/companion-20-pbm-guidelines_0.docx 621236 10710 1.050761908
/system/files/documents/companion-20-pbm-guidelines.pdf 330070 0 1.510425083
/system/files/documents/companion-21-pbm-guidelines.docx 628706 10475 2.251563769
/system/files/documents/companion-21-pbm-guidelines.pdf 335614 0 0.847772395
/system/files/documents/companion-22-pbm-guidelines.docx 77339 1405 0.8243446
/system/files/documents/companion-22-pbm-guidelines.pdf 32006 0 0.856081317
/system/files/documents/companion-23-pbm-guidelines.docx 621549 10331 0.840918748
/system/files/documents/companion-23-pbm-guidelines.pdf 333434 0 0.767180466
/system/files/documents/companion-24-pbm-guidelines.docx 642844 10679 1.019184012
/system/files/documents/companion-24-pbm-guidelines.pdf 338772 0 2.095170286
/system/files/documents/companion-25-pbm-guidelines.docx 637456 10553 2.625953382
/system/files/documents/companion-25-pbm-guidelines.pdf 333954 0 1.311195284
/system/files/documents/companion-26-pbm-guidelines.docx 623771 9935 1.238540985
/system/files/documents/companion-26-pbm-guidelines.pdf 333426 0 0.784094362
/system/files/documents/companion-27-pbm-guidelines.docx 648988 11337 1.951505149
/system/files/documents/companion-27-pbm-guidelines.pdf 342116 0 1.868236301
/system/files/documents/companion-2-pbm-guidelines_0.pdf 57823 0 0.782485199
/system/files/documents/companion-2-pbm-guidelines.docx 76304 1438 1.205470668
/system/files/documents/companion-3-pbm-guidelines_0.pdf 338491 0 1.115799669
/system/files/documents/companion-3-pbm-guidelines.docx 636861 11275 0.835049343
/system/files/documents/companion-4-pbm-guidelines_0.docx 635827 10190 0.680765149
/system/files/documents/companion-4-pbm-guidelines_0.pdf 343617 0 0.711648281
/system/files/documents/companion-5-pbm-guidelines_0.pdf 357783 0 0.611428519
/system/files/documents/companion-5-pbm-guidelines.docx 647213 10656 0.706318808
/system/files/documents/companion-6-pbm-guidelines_0.pdf 348934 0 0.667127493
/system/files/documents/companion-6-pbm-guidelines.docx 619495 10235 0.763468885
/system/files/documents/companion-7-pbm-guidelines_0.pdf 331061 0 0.780799126
/system/files/documents/companion-7-pbm-guidelines.docx 625379 10062 1.753903006
/system/files/documents/companion-8-pbm-guidelines.docx 627033 10128 0.681265943
/system/files/documents/companion-8-pbm-guidelines.pdf 332066 0 0.912263037
/system/files/documents/companion-9-pbm-guidelines_0.pdf 343536 0 0.619752372
/system/files/documents/companion-9-pbm-guidelines.docx 627206 11026 0.942007758
/system/files/documents/companion-appendix1-pbm-guidelines.pdf 363971 0 2.39219437
/system/files/documents/companion-appendix%201-pbm-guidelines.docx 685544 11469 1.427604989
/system/files/documents/cover-sheet-temp-register-form_0.docx 161132 1714 0.772707071
/system/files/documents/cover-sheet-temp-register-form_0.pdf 226775 0 0.767723713
/system/files/documents/darren-cox-is-infectious-disease-the-biggest-threat-to-the-worlds-blood-supply-2013-session-2-speaker-7.pdf 261464 0 1.373588162
/system/files/documents/data-request-form_0.docx 43849 794 0.719938987
/system/files/documents/data-request-form_0.pdf 196018 0 0.766014624
/system/files/documents/david-cross-qc-mysteries-do-you-really-know-what-you-are-controlling-2012-session-3-speaker-5.pdf 151401 0 0.725846709
/system/files/documents/david-mahon-differention-of-neutrophil-auto-antibodies-against-protinase-3-and-hna-2-2013-session-6-speaker-5.pdf 473173 0 0.788739439
/system/files/documents/dion-triffit-csi-tasmania-2012-session-2-speaker-7.pdf 804563 0 1.174659426
/system/files/documents/dot-stern-and-debbie-mills-wallbridge-hdnb-anti-kpa-2011-session-1-speaker-1.pdf 690912 0 0.807792853
/system/files/documents/dot-stern-hyperhaemolysis-syndrome-in-thalassaemia-major-2012-session-5-speaker-1.pdf 852546 0 0.711401214
/system/files/documents/dot-stern-yet-another-anti-d-in-an-rhd-positive-patient-2013-session-5-speaker-1.pdf 3848558 0 0.604788075
/system/files/documents/emerging-infectious-disease-risks-in-the-blood-sector-with-cover.pdf 254200 0 0.966294811
/system/files/documents/erratum-mod6-qrg-update-jan-2017.pdf 39377 0 1.186378677
/system/files/documents/erratum-mod6-update-jan-2017.pdf 40271 0 1.510074194
/system/files/documents/exec-summary.pdf 754469 0 0.751417733
/system/files/documents/faqs-subcutaneous-immunoglobulin-changes-September2016.docx 152489 1704 1.110113491
/system/files/documents/farema-poyan-high-titre-anti-ab-testing-of-the-group-o-platelet-donors-2013-session-2-speaker-1.pdf 651346 0 0.808234572
/system/files/documents/fate-allocate-and-dispense.docx 1008119 15831 0.584841873
/system/files/documents/fate-allocate-and-dispense.pdf 174759 0 0.756559097
/system/files/documents/fate-conversion_0.pdf 171029 0 0.743325901
/system/files/documents/fate-conversion.docx 994405 15286 0.764785643
/system/files/documents/fate-return-to-stock.docx 1013021 15741 0.571876892
/system/files/documents/fate-return-to-stock.pdf 179987 0 0.691214732
/system/files/documents/fate-workflow.docx 807741 10885 0.792933405
/system/files/documents/fate-workflow.pdf 135295 0 0.797374041
/system/files/documents/feedback-to-the-proposed-changes-to-the-criteria-and-nba-responses2015-without-names.docx 374176 5223 1.165284683
/system/files/documents/feedback-to-the-proposed-changes-to-the-criteria-and-nba-responses2015-without-names.pdf 574805 0 1.381408142
/system/files/documents/fetal-and-neonatal-alloimmune-thrombocytopenia%28fnait%29_0.DOCX 66281 1113 0.737228053
/system/files/documents/fetal-and-neonatal-alloimmune-thrombocytopenia%28fnait%29_0.PDF 185786 0 0.731500406
/system/files/documents/fit-for-surgery-algorithm-chronic_0.pdf 206348 0 1.261743414
/system/files/documents/fit-for-surgery-algorithm-da-normal.pdf 207127 0 1.062418878
/system/files/documents/fit-for-surgery-factsheet.PDF 183845 0 0.748966663
/system/files/documents/fit-for-surgery-referral-letter-example.pdf 221489 0 0.740525389
/system/files/documents/flowchart-bloodnet-lis.jpg 144200 0 0.712336756
/system/files/documents/garry-way-bloodnet-reporting-reporting-functionality-2013-session-3-speaker-1.pdf 1565031 0 0.639090225
/system/files/documents/geoff-magrin-transfusion-qap-a-review-of-serological-techniques-2011-session-3-speaker-2.pdf 473626 0 0.7465756
/system/files/documents/glenda-mann-the-aims-fellowship%2C-the-journey-continues-2013-%20session-6-speaker-4.pdf 4012808 0 0.62895764
/system/files/documents/glines-anti-d.pdf 836968 0 1.06959215
/system/files/documents/Guide-to-blood-transfusions-factsheet-AMENDED.PDF 224745 0 0.74348323
/system/files/documents/guillain-barr%C3%A9-syndrome%28gba%29_0.PDF 200107 0 0.742929017
/system/files/documents/guillain-barr%C3%A9-syndrome%28gba%29.DOCX 65615 1160 0.779595079
/system/files/documents/Haemolytic%20disease%20of%20the%20fetus%20and%20newborn%20%28HDFN%29_0.DOCX 32908 524 0.680897807
/system/files/documents/Haemolytic%20disease%20of%20the%20fetus%20and%20newborn%20%28HDFN%29_0.PDF 132715 0 0.799488675
/system/files/documents/Haemophagocytic%20syndrome_0.DOCX 63075 1101 0.728818961
/system/files/documents/Haemophagocytic%20syndrome_0.PDF 138250 0 0.783548956
/system/files/documents/haemovigilance-report-2013-faqs.docx 157035 1736 0.888803641
/system/files/documents/haemovigilance-report-2013-faqs.pdf 220383 0 0.755018134
/system/files/documents/haemovigilance-report-2013.pdf 3699916 0 0.680526324
/system/files/documents/HAPS-Video-1-transcript-inventory-and-delivery-management_0.docx 144820 1498 1.121232242
/system/files/documents/HAPS-Video-1-transcript-inventory-and-delivery-management_0.pdf 176296 0 1.281275138
/system/files/documents/HAPS-Video-3-transcript-hieracrchy_0.pdf 152379 0 0.719617924
/system/files/documents/HAPS-Video-3-transcript-hieracrchy.docx 144531 1499 0.562766574
/system/files/documents/HAPS-Video-4-transcript-speed-of-release_0.docx 144847 1498 1.292919467
/system/files/documents/HAPS-Video-4-transcript-speed-of-release_0.pdf 153850 0 1.179600249
/system/files/documents/HAPS-Video-5-transcript-involved-haematologists_0.pdf 154119 0 2.58573797
/system/files/documents/HAPS-Video-5-transcript-involved-haematologists_1.docx 144897 1492 2.470657593
/system/files/documents/HAPS-Video-6-transcript-stock-rotation_0.docx 144928 1507 1.110681405
/system/files/documents/HAPS-Video-6-transcript-stock-rotation_0.pdf 155526 0 1.040526333
/system/files/documents/health-provider-blood-and-blood-products-charter-gps-and-other_0.docx 985328 13748 0.679857845
/system/files/documents/health-provider-blood-and-blood-products-charter-gps-and-other_0.pdf 531324 0 0.585194954
/system/files/documents/health-provider-blood-and-blood-products-charter-hospitals_0.docx 984849 13742 1.041488175
/system/files/documents/health-provider-blood-and-blood-products-charter-hospitals_0.pdf 482494 0 1.236739782
/system/files/documents/health-provider-blood-and-blood-products-charter-labs_0.pdf 530668 0 0.553505654
/system/files/documents/health-provider-blood-and-blood-products-charter-labs.docx 983672 13762 1.032283831
/system/files/documents/health-provider-verification-of-supplier-performance%20%282%29_0.pdf 272002 0 1.074162372
/system/files/documents/health-provider-verification-of-supplier-performance%20%282%29.docx 147268 1472 1.089997862
/system/files/documents/heather-scarlet-autoimmune-haemolytic-anaemia-in-a-patient-with-cll-2013-session-1-speaker-7.pdf 8417663 0 0.592242168
/system/files/documents/helen-bardsley-fviii-inhibitor-use-of-novo7-2011-session-5-speaker-1.pdf 775629 0 0.692415524
/system/files/documents/helen-bardsley-neontal-exchange-transfusion-2012-session-2-speaker-1.pdf 1023427 0 0.520393702
/system/files/documents/helen-bardsley-transfusion-reaction-or-haemolysis-2013-session-2-speaker-3.pdf 6796800 0 0.591518307
/system/files/documents/helen-bardsley-weaving-through-the-webb-2010-session-2-speaker-1_0.PDF 991335 0 0.78745542
/system/files/documents/helen-henry-mild-haemolytic-disease-of-the-newborn-due-to-anti-g-2013-session-6-speaker-2.pdf 72236 0 0.594161022
/system/files/documents/hossain-khunder-kidd-stuff-2012-session-1-speaker-7_0.pdf 3300601 0 0.713446979
/system/files/documents/htc-implementation-protocol.docx 198932 3663 0.599896851
/system/files/documents/htc-implementation-protocol.pdf 118041 0 0.824264304
/system/files/documents/hub-spoke.gif 30960 0 1.28420065
/system/files/documents/ics-appendixes-march-2014_1.docx 565279 10870 0.628467718
/system/files/documents/ics-appendixes-march-2014_1.pdf 441487 0 0.838724597
/system/files/documents/ics-guidance-march-2014_1.docx 558573 10867 1.251169597
/system/files/documents/ics-guidance-march-2014_1.pdf 352893 0 1.238766124
/system/files/documents/Ig%20Governance%20National%20Policy%20Website.pdf 4322937 0 1.182873548
/system/files/documents/ig-gov-and-system-privacy-impact-assesmt-rprt.DOCX 541337 9643 1.093082253
/system/files/documents/ig-gov-and-system-privacy-impact-assesmt-rprt.pdf 911624 0 1.363616713
/system/files/documents/igm-paraproteinaemic-demyelinating-neuropathy_1.DOCX 67886 1258 0.677976187
/system/files/documents/igm-paraproteinaemic-demyelinating-neuropathy_1.PDF 161074 0 0.741370611
/system/files/documents/immune-thrombocytopenic-purpura-%28itp%29-adult_0.DOCX 114232 2191 0.700280915
/system/files/documents/immune-thrombocytopenic-purpura-%28itp%29-adult.PDF 303906 0 0.74400156
/system/files/documents/immune-thrombocytopenic-purpura-%28itp%29-in%20children%2015%20years%20and%20younger_0.DOCX 80451 1477 0.652760555
/system/files/documents/immune-thrombocytopenic-purpura-%28itp%29-in%20children%2015%20years%20and%20younger_0.PDF 202884 0 0.695830172
/system/files/documents/ina-messig-and-natalie-caldwell-2013-session-3-speaker-3-one-in-a-million.pdf 5568707 0 0.650577807
/system/files/documents/inflammatory-myopathies-inclusion-body-myositis%28ibm%29_0.DOCX 43119 815 0.708923742
/system/files/documents/inflammatory-myopathies-inclusion-body-myositis%28ibm%29.PDF 152755 0 0.612394303
/system/files/documents/inflammatory-myopathies-polymyositis%28pm%29-dermatomyositis%28dm%29-and-necrotising-autoimmune-myopathy%28nam%29_0.PDF 186258 0 0.734645175
/system/files/documents/inflammatory-myopathies-polymyositis%28pm%29-dermatomyositis%28dm%29-and-necrotising-autoimmune-myopathy%28nam%29.DOCX 52668 896 0.68486693
/system/files/documents/Infographicv0.4.pdf 135002 0 0.719188492
/system/files/documents/inital-australian-haemovigilance-report-2008_0.pdf 571701 0 0.638628844
/system/files/documents/Iron%20product%20choice%20and%20dose%20calculation20052016.pdf 463067 0 1.060587716
/system/files/documents/iron-product-choice-and-dose-calculation-adults-20052016.docx 1297478 21513 0.763200888
/system/files/documents/ivig-report-09-10.docx 6088023 113459 1.00287586
/system/files/documents/ivig-report-09-10.pdf 1001311 0 0.780128186
/system/files/documents/jacqueline-shaw-liver-kidney-surprise-2012-session-2-speaker-4.pdf 250114 0 0.774658236
/system/files/documents/jaime-sun-oh-bombay-2013-session-6-speaker-1.pdf 485090 0 0.810192837
/system/files/documents/jenny-morrison-from-an-a-to-f-2013-session-3-speaker-7.pdf 556876 0 0.700758782
/system/files/documents/jo-cameron-a-hot-blood-topic-2010-session-4-poster-3.PDF 2857829 0 0.784424915
/system/files/documents/jo-cameron-and-lyndsay-wall-some-current-projects-underway-at-the-national-blood-authority-2013-session-4-speaker-6.pdf 2734982 0 0.76465091
/system/files/documents/jo-cameron-anti-a1-clinical-significance-2011-session-2-speaker-3.pdf 205145 0 0.821724468
/system/files/documents/jo-cameron-the-national-blood-authority-and-inventory-%20management-2012-session-3-speaker-8.pdf 1558812 0 0.701013638
/system/files/documents/john-hunter-haematologists_0.mp4 25761047 0 2.638137046
/system/files/documents/john-hunter-hierarchy_0.mp4 8930615 0 0.703577267
/system/files/documents/john-hunter-inventory-delivery-management.mp4 19165940 0 1.148044631
/system/files/documents/john-hunter-speed-of-release_0.mp4 20790447 0 1.235069261
/system/files/documents/john-hunter-stock-rotation.mp4 25619674 0 1.302420531
/system/files/documents/joycelyn-woo-and-zueshuang-sherry-lui-complications-of-repeated-transfusions-2013-Session-2-speaker-5.pdf 1969381 0 0.786183944
/system/files/documents/kasia-milczarek-and-madelen-chikhani-2013-session-2-speaker-6-intragam-transfuse-with-caution.pdf 3353536 0 0.675186114
/system/files/documents/kate-mcwhirter-when-none-becomes-four-2011-session-2-speaker-8.pdf 138926 0 0.712655959
/system/files/documents/kawasaki-disease_0.DOCX 62172 1028 0.822111426
/system/files/documents/kawasaki-disease.PDF 151714 0 0.74344223
/system/files/documents/kelly-sliwinski-severe-prolonged-anaemia-associated-with-hdfn-%202013-session-1-speaker-2.pdf 1454859 0 0.718979727
/system/files/documents/kelly-whettingsteel-the-changing-face-of-australia-2013-session-5-speaker-5.pdf 1001377 0 0.803674346
/system/files/documents/khundker-hossain-hereditary-angioedema-a-case-study-2013-session-3-speaker-2.pdf 2568569 0 0.745279461
/system/files/documents/kidney-transplantation_0.DOCX 53063 1085 0.671636945
/system/files/documents/kidney-transplantation_1.PDF 203383 0 0.747003507
/system/files/documents/kirk-sowinski-a-spate-of-nait-2013-session-1-speaker-1.pdf 784117 0 0.679183061
/system/files/documents/kylie-rushford-an-audit-of-transfusion-practice-and-wastage-of-paediatric-red-cells-2011-session-3-speaker-3_0.pdf 268970 0 0.781931869
/system/files/documents/kylie-rushford-rhd-ig-therapy-in-itp-2012-session-3-speaker-3.pdf 1026241 0 0.687209278
/system/files/documents/lambert-eaton-myasthenic-syndrome%28lems%29_0.DOCX 47482 870 0.755206271
/system/files/documents/lambert-eaton-myasthenic-syndrome%28lems%29_0.PDF 153093 0 0.796623608
/system/files/documents/launchpres.pdf 603176 0 0.96082893
/system/files/documents/launchpres.pptx 3359312 65536 0.82901643
/system/files/documents/launchtranscript.docx 24449 470 0.709990964
/system/files/documents/launchtranscript.pdf 137133 0 0.766440104
/system/files/documents/lindsay-laurie-2013-session-3-speaker-4-unusual-blood-grouping-scenario.pdf 2849587 0 0.79533089
/system/files/documents/liverpool-hospital-rfid-case-study.pdf 608056 0 0.702050279
/system/files/documents/louise-nauenburg-case-study-to-d-or-not-to-d-2011-session-4-speaker-%204_0.pdf 2019872 0 0.580214116
/system/files/documents/MAGNETS_1.pdf 202266 0 0.909320667
/system/files/documents/MAGNETS_2.pdf 74483 0 0.81454441
/system/files/documents/MAGNETS_3_0.pdf 13608 0 0.708962412
/system/files/documents/management-model-fibrinogen-concentrate.docx 146309 1512 0.75986232
/system/files/documents/management-model-fibrinogen-concentrate.pdf 348450 0 0.856332776
/system/files/documents/managing-blood-and-blood-product-inventory.pdf 9311835 0 1.282458815
/system/files/documents/managing-blood-and-blood-product-inventory-reduced-size.pdf 3066160 0 1.186055513
/system/files/documents/managing-my-iron-factsheet.pdf 188175 0 0.655885523
/system/files/documents/march13-update-review.docx 33488 621 1.121955366
/system/files/documents/march13-update-review.pdf 104661 0 1.297849779
/system/files/documents/marni-kerseboom-the-curious-case-of-the-disappearing-anti-d-2010-session-1-speaker-5.PDF 546694 0 0.680314466
/system/files/documents/mary-comande-adapting-an-mtp-for-paediatric-use-2012-session-6-speaker-6.pdf 601817 0 0.649597142
/system/files/documents/melanie-mcmahon-ffp-appropriate-or-not-2011-session-6-speaker-5.pdf 1083467 0 0.591732477
/system/files/documents/melissa-kulig-a-transfusion-case-study-complexities-of-the-rh-blood-group-system-2013-session-1-speaker-6.pdf 1455326 0 0.821260738
/system/files/documents/michael-crennan-resolving-abo-discrepancies-2011-session-4-speaker-5.pdf 40855 0 0.655369997
/system/files/documents/mod1pres.pdf 1860713 0 1.13814519
/system/files/documents/mod1pres.pptx 3005986 49607 1.258508409
/system/files/documents/mod1transcript.docx 20584 357 1.078663592
/system/files/documents/mod1transcript.pdf 153144 0 0.669815781
/system/files/documents/mod2pres.pdf 1493268 0 0.532692258
/system/files/documents/mod2pres.pptx 2195076 37181 0.792996118
/system/files/documents/mod2transcript.docx 23349 442 0.791924251
/system/files/documents/mod2transcript.pdf 130004 0 0.620484106
/system/files/documents/mod3pres.pdf 3185038 0 0.812269263
/system/files/documents/mod3pres.pptx 6105493 100831 0.590202209
/system/files/documents/mod3transcript.docx 24642 391 1.274728662
/system/files/documents/mod3transcript.pdf 136218 0 1.112901491
/system/files/documents/module2-intravenous-and-subcutaneous-immunoglobulin-inventory-management-guidelinesV3.docx 1324090 22866 1.057424094
/system/files/documents/module2-intravenous-and-subcutaneous-immunoglobulin-inventory-management-guidelinesV3.pdf 1935589 0 1.393888391
/system/files/documents/multifocal-motor-neuropathy%28mmn%29_0.DOCX 43885 858 0.726075337
/system/files/documents/multifocal-motor-neuropathy%28mmn%29_0.PDF 181979 0 0.845415556
/system/files/documents/myabdr-media-release-senator-nash-20140321.pdf 257345 0 1.310604962
/system/files/documents/myasthenia-gravis%28mg%29_0.DOCX 48458 945 0.737426757
/system/files/documents/myasthenia-gravis%28mg%29_0.PDF 182720 0 0.75534513
/system/files/documents/nadia-saliba-issues-in-transfusion-safety-2013-session-4-speaker-5.pdf 1557061 0 0.529594191
/system/files/documents/nadine-verdoorn-blood-banking-the-korean-way-2012-session-5-%20speaker-3.pdf 1596130 0 0.713228885
/system/files/documents/nadine-verdoorn-paediatric-heart-transplant-an-incompatible-truth-2011-session-5-speaker-3%202.pdf 2836035 0 0.618116063
/system/files/documents/natalie-stewart-welcome-to-spc-the-arcbs-sydney-processing-centre-2012-session-6-speaker-4.pdf 3400611 0 0.789779296
/system/files/documents/nathan-kruger-bloodportal-and-bloodchat-2012-session-3-speaker-9.pdf 708769 0 0.603915096
/system/files/documents/national-education-and-training-strategy-2013-2016.docx 1792558 23738 0.837907171
/system/files/documents/national-education-and-training-strategy-2013-2016.pdf 572812 0 0.633682103
/system/files/documents/national-haemovigilance-data-dictionary-2010_0.pdf 288471 0 0.871490921
/system/files/documents/National-Immunoglobulin-Governance-Advisory-Committee%28NIGAC%29-Nov%202017.docx 54654 1024 0.74053518
/system/files/documents/nazli-davar-patients-identification-check%2C-how-many-lives-does-it-save-2013-session-4-speaker-7.pdf 408413 0 1.209132233
/system/files/documents/nba-2011-12-highlights-of-monitoring-international-trends.doc 162304 0 0.725980027
/system/files/documents/nba-2011-12-highlights-of-monitoring-international-trends.pdf 121703 0 0.713245157
Letter Template /system/files/documents/nba-%20legal-services-expenditure-2006-07.doc 198144 143 0.746599983
/system/files/documents/nba-abdr-annual-report-2009-10.doc 4560896 0 0.571489708
/system/files/documents/nba-abdr-annual-report-2009-10.pdf 3150054 0 0.577906517
/system/files/documents/nba-abdr-annual-report-annual-2010-11.doc 4737536 0 0.776112258
/system/files/documents/nba-abdr-annual-report-annual-2010-11.pdf 2272934 0 0.828745848
/system/files/documents/nba-annual-report-2003-4.pdf 8942946 0 1.164877283
/system/files/documents/nba-annual-report-2004-5_0.pdf 8035512 0 0.626205378
/system/files/documents/nba-annual-report-2005-6_0.pdf 18874601 0 0.55495205
/system/files/documents/nba-annual-report-2010-11-errata_0.pdf 108235 0 0.684941772
/system/files/documents/nba-april-2013-monitoring-international-trends.doc 51096 0 0.833983508
/system/files/documents/nba-april-2013-monitoring-international-trends.pdf 147723 0 0.947024914
/system/files/documents/nba-august-2011-monitoring-international-trends.doc 467456 0 0.691668399
/system/files/documents/nba-august-2011-monitoring-international-trends.pdf 116948 0 0.725534656
/system/files/documents/nba-august-2012-monitoring-international-trends.doc 133632 0 0.813738425
/system/files/documents/nba-august-2012-monitoring-international-trends.pdf 331896 0 0.886788522
/system/files/documents/nba-blood-sector-data-strategy-2013-2016.docx 1678634 20823 2.051077856
/system/files/documents/nba-blood-sector-data-strategy-2013-2016.pdf 765541 0 1.718590884
/system/files/documents/NBA-Corporate-Plan-2017-18-to-2020-21.pdf 4343029 0 0.798701498
/system/files/documents/nba-data-governance-framework-mar-2015v2.docx 1509528 22751 1.148784588
/system/files/documents/nba-data-governance-framework-mar-2015v2.pdf 1279607 0 1.381179063
/system/files/documents/nba-december-2012-monitoring-international-trends.docx 72744 1341 0.779096121
/system/files/documents/nba-december-2012-monitoring-international-trends.pdf 635261 0 0.806959936
/system/files/documents/nba-ea-2015-2018-web.docx 218371 2813 1.003652499
/system/files/documents/nba-ea-2015-2018-web.pdf 9210153 0 1.679296702
/system/files/documents/nba-february-2012-monitoring-international-trends.doc 401408 0 0.681335421
/system/files/documents/nba-february-2012-monitoring-international-trends.pdf 123867 0 0.671333882
/system/files/documents/nba-february-2013-monitoring-international-trends.docx 66833 1297 0.731715143
/system/files/documents/nba-february-2013-monitoring-international-trends.pdf 206543 0 1.071296883
/system/files/documents/NBA-Grant-Reporting-as-at-27-September-2017.pdf 21956 0 0.699798265
/system/files/documents/NBA-Grant-Reporting-as-at-27-September-2017.XLS 151552 0 0.708780843
/system/files/documents/nba-haemovigilance-report-2015.pdf 2120843 0 0.638521593
/system/files/documents/nba-ivig-annual-report-10-11-amended-dec-2012.doc 5679992 0 0.753558642
/system/files/documents/nba-ivig-annual-report-10-11-amended-dec-2012.pdf 1723128 0 0.670443307
/system/files/documents/nba-ivig-annual-report-2011-12.docx 3401358 56047 0.795159407
/system/files/documents/nba-ivig-annual-report-2011-12.pdf 2107307 0 2.105366245
/system/files/documents/nba-ivig-annual-report-2012-13_2.pdf 1116650 0 0.68328339
/system/files/documents/nba-ivig-annual-report-2012-13.docx 1576704 24224 1.415725394
/system/files/documents/nba-ivig-criteria-for-use-qrg-2nd-edition.pdf 777795 0 0.61961515
/system/files/documents/NBA_IVIgCriteria_SecondEdition_Internals-WEB_updated_ref.pdf 1437104 0 0.727065644
/system/files/documents/nba-january-2013-monitoring-international-trends.docx 105154 2004 0.746895866
/system/files/documents/nba-january-2013-monitoring-international-trends.pdf 206210 0 0.679340528
/system/files/documents/nba-jun-2013-international-trends.docx 69533 1218 0.721061884
/system/files/documents/nba-jun-2013-international-trends.pdf 189560 0 0.995351392
/system/files/documents/nba-june-2012-monitoring-international-trends.doc 156672 0 0.710730012
/system/files/documents/nba-june-2012-monitoring-international-trends.pdf 214513 0 0.819925485
Letter Template /system/files/documents/nba-legal-services-expenditure-2005-06.doc 199680 143 0.752104197
Letter Template /system/files/documents/nba-legal-services-expenditure-2006-07.pdf 37156 143 1.113817345
Letter Template /system/files/documents/nba-legal-services-expenditure-2008-09.doc 220160 192 1.326114517
/system/files/documents/nba-march-2013-monitoring-international-trends.doc 97280 0 0.762151658
/system/files/documents/nba-march-2013-monitoring-international-trends.pdf 506841 0 0.779903899
/system/files/documents/nba-may-2012-monitoring-international-trends.doc 215040 0 0.727943141
/system/files/documents/nba-may-2012-monitoring-international-trends.pdf 223147 0 0.747279442
/system/files/documents/nba-may-2013-international-trends.docx 49914 900 0.797935708
/system/files/documents/nba-may-2013-international-trends.pdf 132937 0 0.788474017
/system/files/documents/nba-national-blood-agreement-full-varied.pdf 138402 0 0.915080657
/system/files/documents/nba-national-blood-agreement.pdf 3082465 0 1.115654711
/system/files/documents/nba-nbscp-annex-a-redcell.pdf 956929 0 1.020444232
/system/files/documents/nba-nbscp-annex-b-plasma.pdf 958218 0 1.225127982
/system/files/documents/nba-nbscp.pdf 1503135 0 1.370661014
/system/files/documents/nba-nbscp-qrg-prioritisation.pdf 49656 0 0.601340348
/system/files/documents/nba-nbscp-qrg-roles-responsibilities.pdf 38387 0 0.7466522
/system/files/documents/nba-november-2011-monitoring-international-trends.doc 511488 0 0.783292558
/system/files/documents/nba-november-2011-monitoring-international-trends.pdf 161334 0 0.711172494
/system/files/documents/nba-november-2012-monitoring-international-trends_0.pdf 162135 0 0.80950735
/system/files/documents/nba-november-2012-monitoring-international-trends.docx 67957 1260 0.74447966
/system/files/documents/nba-october-2012-monitoring-international-trends.docx 74075 1344 0.71498103
/system/files/documents/nba-october-2012-monitoring-international-trends.pdf 134223 0 0.731385317
/system/files/documents/nba-patient-blood-management-resource-guide-nov_2016_v3_sm_web_file.pdf 1097293 0 0.907978717
/system/files/documents/nba-privacy-policy_0.pdf 108654 0 0.713571109
/system/files/documents/nba-privacy-policy_1.docx 33194 615 0.728857674
/system/files/documents/nba-research-and-development-priorities-2013-16.doc 2260480 0 0.997925732
/system/files/documents/nba-research-and-development-priorities-2013-16.pdf 834332 0 1.423548669
/system/files/documents/nba-standard-terms-conditions.docx 175679 1868 1.067429776
/system/files/documents/nba-standard-terms-conditions.pdf 269501 0 0.708725421
/system/files/documents/nba-stewardship-stewardship-statement.doc 41984 0 0.740289146
/system/files/documents/nba-stewardship-stewardship-statement.pdf 16933 0 0.741298789
/system/files/documents/nba-wastage-strategy.docx 346130 5174 1.111764382
/system/files/documents/nba-wastage-strategy.pdf 365600 0 1.331939498
/system/files/documents/nbscp-annex-c-platelets-endorsed-%20web-version-new-formatting-may-2015.pdf 500147 0 0.76219051
/system/files/documents/neonatal-haemochromatosis%28nh%29_0.DOCX 60418 1147 0.731336698
/system/files/documents/neonatal-haemochromatosis%28nh%29_0.PDF 173600 0 0.760319778
/system/files/documents/nhig-order-form-2018.DOT 133120 0 0.738940749
/system/files/documents/nhig-order-form-2018.PDF 287130 0 0.772629928
/system/files/documents/nicole-filipinski-oh-oh-octagam-2013-session-2-speaker-4_0.pdf 949162 0 0.684035841
/system/files/documents/nigac-terms-of-reference.docx 57388 970 1.032505358
/system/files/documents/nimf-pilot-duration.jpg 50846 0 0.658534367
/system/files/documents/nimf-progress-update-9-december%202015.DOCX 50819 888 1.125310717
/system/files/documents/nimf-progress-update-9-december%202015.pdf 138509 0 1.022511547
/system/files/documents/nimf-progress-update-august-2013.docx 69654 1296 0.758802711
/system/files/documents/nimf-progress-update-august-2013.pdf 133352 0 0.682682743
/system/files/documents/nimf-progress-update-august-2014_0.pdf 136789 0 0.652340332
/system/files/documents/nimf-progress-update-august-2014.docx 56432 946 0.797334613
/system/files/documents/nimf-progress-update-july-2013.docx 69578 1285 0.678436373
/system/files/documents/nimf-progress-update-july-2013.pdf 134332 0 0.728975887
/system/files/documents/nimf-progress-update-november-2013.docx 40640 875 0.811992428
/system/files/documents/nimf-progress-update-november-2013.pdf 484039 0 0.813208329
/system/files/documents/nimf-progress-update-september-2013.docx 141932 2950 0.765039671
/system/files/documents/nimf-progress-update-september-2013.pdf 482645 0 0.728464511
/system/files/documents/nimf-project-information.doc 62976 0 0.83099577
/system/files/documents/nimf-project-information.pdf 53260 0 1.365781356
/system/files/documents/nimf-project-progress-update-january-2013.docx 123502 2081 0.694013153
/system/files/documents/nimf-project-progress-update-january-2013.pdf 141228 0 0.681036206
/system/files/documents/NIMF_Project_Progress_Update_January_2015.docx 50332 862 0.762441291
/system/files/documents/NIMF_Project_Progress_Update_January_2015.pdf 382547 0 0.810432378
/system/files/documents/nimf-project-progress-update-june-2013.docx 121520 2549 0.74830607
/system/files/documents/nimf-project-progress-update-june-2013.pdf 123022 0 0.842522978
/system/files/documents/obtaining-fridge-compliance.docx 888492 12531 0.653018307
/system/files/documents/obtaining-fridge-compliance.pdf 176214 0 0.654173759
/system/files/documents/October%202014%20website%20final.docx 89662 1763 0.756332453
/system/files/documents/October%202014%20website%20final.pdf 220997 0 0.779162927
/system/files/documents/opsoclonus-myoclonus-ataxia%28oma%29_0.DOCX 42857 827 0.759089078
/system/files/documents/opsoclonus-myoclonus-ataxia%28oma%29_0.PDF 193102 0 0.72081892
/system/files/documents/Organisational-chart-fig1.1.pdf 802129 0 0.571294285
/system/files/documents/overseas-use-clinical-approval.pdf 24281 0 1.194327487
/system/files/documents/overseas-use-factsheet.pdf 58991 0 1.383541087
/system/files/documents/p1.3_sa_blood_fridge_register_poster.pdf 1329916 0 0.640315809
/system/files/documents/Pages%20from%20preoperative-bleeding-risk-assessment-qrg.pdf 264204 0 1.960237466
/system/files/documents/pam-hudson-instrument-qc-2010-session-3-speaker-7.PDF 586411 0 0.549872818
/system/files/documents/path-service-obligations-standard7-letter-template.docx 23090 411 1.298403351
/system/files/documents/path-service-obligations-standard7-letter-template.pdf 121353 0 1.086978036
/system/files/documents/patient-blood-management-guidelines-companions.docx 16971319 296914 1.033029848
/system/files/documents/patient_blood__management_guidelines_companions.pdf 7854002 0 1.135411791
/system/files/documents/patient-information-brochure.docx 476548 9390 0.971539979
/system/files/documents/patient-information-brochure.pdf 119150 0 0.571766499
/system/files/documents/patient-information-subcutaneous-immunoglobulin-treatment_20160308.docx 2743556 46681 1.162345722
/system/files/documents/patient-registration-form.docx 210608 3885 0.580052596
/system/files/documents/patient-registration-form.pdf 86191 0 0.705167965
/system/files/documents/patricia-natoli-transfusion-medicine-in-remote-isolated-locations-2013-session-4-speaker-4.pdf 4394364 0 0.703121446
/system/files/documents/pauline-hinks-cost-of-transfusion-2012-session-4-speaker-9.pdf 623039 0 0.584064141
/system/files/documents/pauline-hinks-who-said-being-a-kidd-was-easy-2013-session-5-speaker-4.pdf 1647085 0 0.664943275
/system/files/documents/pauline-hinks-wrong-blood-given-to-patient-2010-session-2-speaker-4.PDF 1130321 0 0.631526158
/system/files/documents/pbm-3-pillars.pdf 1316405 0 1.936485487
/system/files/documents/pbm5-e-poster-savoia.pdf 329504 0 0.70676671
/system/files/documents/pbm-guidelines-implementation-strategy-november.docx 563207 9198 0.800169337
/system/files/documents/pbm-guidelines-implementation-strategy-november.pdf 728207 0 0.516794418
/system/files/documents/pbm-mod-5_0.pdf 6138337 0 1.255434427
/system/files/documents/pbm-mod-5-qrg.pdf 1404126 0 1.22600876
/system/files/documents/pbm-module1-mtp-template_0.ppt 431616 0 1.076183943
/system/files/documents/pbm-module-1.pdf 4411492 0 0.592826677
/system/files/documents/pbm-module-1-qrg.pdf 2816051 0 0.772091479
/system/files/documents/pbm-module1-tech-vol1_0.pdf 1975726 0 1.053370799
/system/files/documents/pbm-module1-tech-vol2.pdf 3402184 0 0.551482689
/system/files/documents/pbm-module-2.pdf 16483790 0 1.369390274
/system/files/documents/pbm-module-2-qrg.pdf 843743 0 0.87091663
/system/files/documents/pbm-module2-tech-vol1a_0.pdf 3338260 0 0.855736637
/system/files/documents/pbm-module2-tech-vol1b_0.pdf 3262859 0 0.587425402
/system/files/documents/pbm-module2-tech-vol2a_0.pdf 7174001 0 0.726931366
/system/files/documents/pbm-module2-tech-vol2b_0.pdf 9435568 0 0.862788899
/system/files/documents/pbm-module-3-qrg.pdf 1081838 0 0.696666142
/system/files/documents/pbm-module3-tech-vol1_0.pdf 4581812 0 0.550114718
/system/files/documents/pbm-module3-tech-vol2_0.pdf 20660057 0 1.058087611
/system/files/documents/pbm-module-4.pdf 1304171 0 1.090564982
/system/files/documents/pbm-module-4-qrg.pdf 1223784 0 0.791188829
/system/files/documents/pbm-module4-tech-vol1_0.pdf 1845216 0 0.687952041
/system/files/documents/pbm-module4-tech-vol2_0.pdf 3120919 0 0.937841934
/system/files/documents/pbm-mtp-template_0.ppt 760832 0 0.495272666
/system/files/documents/pbm-preoperative-template_0.pptx 179076 2815 1.043702196
/system/files/documents/pbmsc-governance-arrangements-sept-2014.docx 209826 4294 1.144285405
/system/files/documents/pbmsc-governance-arrangements-sept-2014.pdf 274154 0 1.452031916
/system/files/documents/pemphigus-foliaceus%28pf%29_0.DOCX 60210 1101 0.685906166
/system/files/documents/pemphigus-foliaceus%28pf%29_0.PDF 125473 0 0.730556491
/system/files/documents/pemphigus-vulgaris%28pv%29_0.DOCX 62140 1137 0.696604879
/system/files/documents/pemphigus-vulgaris%28pv%29_0.PDF 135283 0 0.763570197
/system/files/documents/peter-andrew-a-very-lucky-lady-2011-session-1-speaker-6.pdf 20063 0 0.733020436
/system/files/documents/philip-rose-ab-case-study-rotten-teeth%2C-valves-and-red-cells-2010-session-2-speaker-6.PDF 567585 0 0.639327003
/system/files/documents/Portal%20-%20national-education-and-training-committee-tor.docx 330446 6493 0.772427369
/system/files/documents/Portal%20-%20national-education-and-training-committee-tor.pdf 229193 0 0.8500518
/system/files/documents/poster-safe-blood--transport-storage_0.pdf 91043 0 0.797392079
/system/files/documents/poster-safe-blood-transport-storage.docx 48261 797 1.127653117
/system/files/documents/post-transfusion-purpura%28ptp%29_0.DOCX 57433 1066 0.768516925
/system/files/documents/post-transfusion-purpura%28ptp%29.PDF 121461 0 0.716031448
/system/files/documents/preoperative-anaemia-identification-assessment-and-management-case-study%20grey%20cover%20v4.pdf 2737180 0 1.221281999
/system/files/documents/preoperative-bleeding-risk-assessment-v5.pdf 1241135 0 0.765982683
/system/files/documents/Prescriber%20acknowledgement%20and%20confirmation-patient%20consent%20151015%20%283%29_0.pdf 121593 0 1.348613586
/system/files/documents/Prescriber%20acknowledgement%20and%20confirmation-patient%20consent%20151015.docx 79445 1511 0.932132406
/system/files/documents/presentation-standard7_0.pdf 3205245 0 0.72233122
/system/files/documents/presentation-standard7.ppt 15545344 0 1.012734302
/system/files/documents/primary-immunodeficiency-diseases%28pid%29-with-antibody-deficiency_0.DOCX 73660 1274 0.733170668
/system/files/documents/primary-immunodeficiency-diseases%28pid%29-with-antibody-deficiency_0.PDF 196803 0 0.637137414
/system/files/documents/print-fridge-checksheet.docx 1156925 19286 1.302768951
/system/files/documents/print-fridge-checksheet.pdf 185696 0 1.175178498
/system/files/documents/pris-moreira-trials-and-tribulations-when-sourcing-blood-with-rare-phenotypes-2013-session-5-speaker-6_0.pdf 795294 0 0.638194899
/system/files/documents/privacy-statement-and-notice2092015_1.pdf 235187 0 1.10927358
/system/files/documents/privacy-statement-and-notice.docx 106851 1850 1.168469678
/system/files/documents/public-interest-disclosure.docx 184557 1956 1.043719306
/system/files/documents/public-interest-disclosure.pdf 251657 0 1.389323777
/system/files/documents/rachelle-liwayan-the-case-of-the-probable-anti-lw-2013-session-3-speaker-5.pdf 312312 0 0.612418429
/system/files/documents/raewyn-cameron-it-ain%E2%80%99t-necessarily-so%21-2011-session-3-speaker-6%20%281%29.pdf 797228 0 0.739693069
/system/files/documents/rebecca-crockett-validation-of-the-fronine-kleihauer-fmh-est-kit-2013-session-6-speaker-3.pdf 296889 0 0.708459361
/system/files/documents/red-cell-%20data-linkage-overview.png 117417 0 1.274439242
/system/files/documents/red-cell-diagnostic-product-list-july-2016-final_0.pdf 90599 0 0.636503664
/system/files/documents/red-cell-diagnostic-product-list-july-2016-final.xlsx 17788 330 0.998762712
/system/files/documents/relapsing-remitting-multiple-sclerosis%28rrms%29_0.DOCX 47087 928 0.699557053
/system/files/documents/relapsing-remitting-multiple-sclerosis%28rrms%29_0.PDF 153381 0 0.856800909
/system/files/documents/report-on-the-issues-and-use-of-ivig-2013-14-finalv2_0.docx 1580434 24132 1.708702025
/system/files/documents/report-on-the-issues-and-use-of-ivig-2013-14-finalv2_0.pdf 1134010 0 4.051092045
/system/files/documents/request-for-approval-of-supply-of-blood-or-blood-products-for-use-overseas.docx 33851 587 0.915692531
/system/files/documents/request-for-approval-of-supply-of-blood-or-blood-products-for-use-overseas.pdf 58847 0 0.94538914
/system/files/documents/request-for-extension-of-supply-of-blood-or-blood-products-for-use-overseas.docx 36053 619 0.943084869
/system/files/documents/request-for-extension-of-supply-of-blood-or-blood-products-for-use-overseas.pdf 55731 0 0.918321416
/system/files/documents/requesting%20data%20flowchart.png 33333 0 0.654343618
/system/files/documents/rhonda-hosken-unruly-cats-naughty-but-nice-2011-session-3-speaker-7.pdf 683545 0 0.717514923
/system/files/documents/rita-sansone-the-21st-century-an-age-of-technology-and-still-no-red-blood-cell-substitute-2011-session-5-speaker-7.pdf 1511767 0 0.74845366
/system/files/documents/robin-parisotto-die-klei-hauer-2011-session-4-speaker-8.pdf 929876 0 0.795337452
/system/files/documents/ryan-lambert-how-a-positive-became-a-negative-2012-session-4-%20speaker-5.pdf 128124 0 0.5699586
/system/files/documents/sarah-eccles-can%20t-see-the-wood-for-the-trees-2011-session-1-speaker-8.pdf 510861 0 0.623151956
/system/files/documents/sarah-eccles-compound-rh-antigens%2C-their-molecular-basis-and-implications-for-transfusion-2013-session-1-speaker-4_0.pdf 2904984 0 0.702579311
/system/files/documents/sarah-eccles-enzyme-in-biovue-2010-session-3-speaker-4.PDF 1975296 0 0.736172675
/system/files/documents/scgh-pbm-decision-to-transfuse-flowchart.pdf 234400 0 1.810121252
/system/files/documents/SCIg-hospital-acknowledgment-form-2017-17Oct17.docx 154635 1626 1.031375757
/system/files/documents/SCIg-hospital-acknowledgment-form-2017-17Oct17.pdf 356864 0 0.802122448
/system/files/documents/scig-patient-receipt-and-use-diary-august-2013.pdf 37207 0 0.57497197
/system/files/documents/scig-patient-receipt-and-use-diary-august-2013.xlsx 12443 194 0.769405253
/system/files/documents/scig-training-checklist-for-patients.docx 27147 453 1.045477433
/system/files/documents/scig-training-checklist-for-patients.pdf 80778 0 1.412683518
/system/files/documents/scig-trifold-patient-information-brochure20160307.pdf 651598 0 0.774271037
/system/files/documents/secondary-hypogammaglobulinaemia-related-to-haematological-malignancies-and-post-haemopoietic-stem-cell-transplantation_1.DOCX 75175 1393 0.705536224
/system/files/documents/secondary-hypogammaglobulinaemia-related-to-haematological-malignancies-and-post-haemopoietic-stem-cell-transplantation_1.PDF 192662 0 0.735046226
/system/files/documents/secondary-hypogammaglobulinaemia-unrelated-to-haematological-malignancy-or-haemopoeitic-stem-cell-transplant-hsct_1.DOCX 70789 1236 0.723373506
/system/files/documents/secondary-hypogammaglobulinaemia-unrelated-to-haematological-malignancy-or-haemopoeitic-stem-cell-transplant-hsct_4.PDF 171025 0 0.735474704
/system/files/documents/sector-monitoring-2013-august.docx 76666 1383 0.712543576
/system/files/documents/sector-monitoring-2013-august.pdf 246656 0 0.810688155
/system/files/documents/sector-monitoring-2013-july.docx 83373 1583 0.801409234
/system/files/documents/sector-monitoring-2013-july.pdf 767895 0 0.545140282
/system/files/documents/sector-monitoring-2013-november-december_0.docx 77251 1412 0.855464644
/system/files/documents/sector-monitoring-2013-november-december.pdf 212991 0 0.757198744
/system/files/documents/sector-monitoring-2013-october.docx 54325 1007 0.72694012
/system/files/documents/sector-monitoring-2013-october.pdf 162020 0 0.839524138
/system/files/documents/sector-monitoring-2013-september.docx 57724 1053 0.770408129
/system/files/documents/sector-monitoring-2013-september.pdf 194690 0 0.930673532
/system/files/documents/sector-monitoring-2014-april_0.docx 75396 1368 0.759233442
/system/files/documents/sector-monitoring-2014-april_1.pdf 220373 0 0.68807779
/system/files/documents/sector-monitoring-2014-august_1.docx 123653 2339 0.740260519
/system/files/documents/sector-monitoring-2014-august_1.pdf 465727 0 1.147369268
/system/files/documents/sector-monitoring-2014-december.docx 67821 1134 0.769939262
/system/files/documents/sector-monitoring-2014-december.pdf 209874 0 0.855238071
/system/files/documents/sector-monitoring-2014-february.docx 79639 1495 0.66939989
/system/files/documents/sector-monitoring-2014-february.pdf 241665 0 0.616338172
/system/files/documents/sector-monitoring-2014-january.docx 86875 1590 0.707784697
/system/files/documents/sector-monitoring-2014-january.pdf 250134 0 0.872599852
/system/files/documents/sector-monitoring-2014-march.docx 73392 1367 0.684963825
/system/files/documents/sector-monitoring-2014-march.pdf 241096 0 0.745324639
/system/files/documents/sector-monitoring-2014-may-june.docx 132546 2558 0.823959784
/system/files/documents/sector-monitoring-2014-may-june.pdf 777880 0 0.834137236
/system/files/documents/sector-monitoring-2014-sept_0.pdf 531153 0 0.531050652
/system/files/documents/sector-monitoring-2014-sept.docx 102361 2087 0.780352977
/system/files/documents/sector-monitoring-2015-apr_0.docx 88693 1689 0.723083971
/system/files/documents/sector-monitoring-2015-apr_0.pdf 249816 0 0.652988408
/system/files/documents/sector-monitoring-2015-feb_1.pdf 272587 0 0.796968408
/system/files/documents/sector-monitoring-2015-feb.docx 89159 1706 0.686605733
/system/files/documents/sector-monitoring-2015-jan.docx 86920 1632 0.747115663
/system/files/documents/sector-monitoring-2015-january-0.pdf 216469 0 0.751102483
/system/files/documents/sector_monitoring_2015_july.docx 89050 1669 0.708859087
/system/files/documents/sector_monitoring_2015_july.pdf 231121 0 0.783269894
/system/files/documents/sector_monitoring_2015_june_0.docx 86802 1517 0.762410962
/system/files/documents/sector_monitoring_2015_june.pdf 238819 0 0.633427291
/system/files/documents/sector-monitoring-2015-mar.docx 88132 1644 0.766561727
/system/files/documents/sector-monitoring-2015-mar.pdf 243097 0 0.706336832
/system/files/documents/sector-monitoring-2015-may_0.docx 98642 1982 0.737665914
/system/files/documents/sector-monitoring-2015-may.pdf 317137 0 0.769972008
/system/files/documents/sector-monitoring-apr-2016.docx 95280 1775 0.617890583
/system/files/documents/sector-monitoring-apr-2016.pdf 315151 0 0.77051819
/system/files/documents/sector_monitoring_aug_2015.docx 87887 1618 0.740151631
/system/files/documents/sector_monitoring_aug_2015.pdf 260393 0 1.002020844
/system/files/documents/sector-monitoring-jan-feb-2016.docx 91589 1779 0.766214713
/system/files/documents/sector-monitoring-jan-feb-2016.pdf 312394 0 0.691942372
/system/files/documents/sector-monitoring-july-2014_0.docx 97685 1925 0.721351848
/system/files/documents/sector-monitoring-july-2014.pdf 415715 0 0.734679633
/system/files/documents/sector-monitoring-mar-2016_1.docx 94828 1695 0.679395369
/system/files/documents/sector-monitoring-mar-2016.pdf 332523 0 0.901518775
/system/files/documents/sector-monitoring-nov-2015_0.pdf 305543 0 0.718638144
/system/files/documents/sector-monitoring-nov-2015.docx 91249 1594 0.723473908
/system/files/documents/sector-monitoring-oct-2015.docx 74320 1419 0.714538305
/system/files/documents/sector-monitoring-oct-2015.pdf 717569 0 0.613996238
/system/files/documents/sector-monitoring-oct-2016.docx 84019 1622 0.636730064
/system/files/documents/sector-monitoring-oct-2016.pdf 281925 0 0.782569824
/system/files/documents/sector-monitoring-report-april-may-2017-_5.docx 89806 1709 0.64877621
/system/files/documents/sector-monitoring-report-april-may-2017-.pdf 219020 0 0.840480132
/system/files/documents/sector-monitoring-report-dec-17-jan-18.docx 101742 1947 1.118962492
/system/files/documents/sector-monitoring-report-dec-17-jan-18.pdf 265367 0 1.334101644
/system/files/documents/sector-monitoring-sept-2015.docx 78957 1392 0.517642905
/system/files/documents/sector-monitoring-sept-2015.pdf 251289 0 0.786960664
/system/files/documents/sector-monitring-dec-2015.docx 87295 1582 1.016779616
/system/files/documents/sector-monitring-dec-2015.pdf 295912 0 1.272627108
/system/files/documents/seyed-reza-mortazavi-platelet-transfusion-refractoriness-2013-session-5-speaker-2.pdf 441066 0 0.76818057
/system/files/documents/shared-inventory-search.docx 923197 13518 0.564361091
/system/files/documents/shared-inventory-search.pdf 148353 0 0.714124783
/system/files/documents/single-unit-transfusion-guide-summary-june-2014.docx 2767160 42651 2.249859152
/system/files/documents/single-unit-transfusion-guide-summary-june-2014.pdf 919290 0 1.147432217
/system/files/documents/solid-organ-transplantation-solid-organ-%28other%20than%20kidney%29_0.DOCX 45683 907 0.660323171
/system/files/documents/solid-organ-transplantation-solid-organ-%28other%20than%20kidney%29_0.PDF 173173 0 0.667504031
/system/files/documents/sophy-suy-flow-cytometry-in-blood-banking-2012-session-4-speaker-2.pdf 952541 0 0.659683117
/system/files/documents/Specialist-Working-Groups-%28SWGs%29-membership-list-Nov2017.docx 39153 689 0.701737749
/system/files/documents/Specialist-Working-Groups-%28SWGs%29-membership-list-Nov2017.pdf 196707 0 0.595245424
/system/files/documents/specific-antibody-deficiency-sad_1.DOCX 77435 1295 0.705619366
/system/files/documents/specific-antibody-deficiency-sad_1.PDF 218763 0 0.770503462
/system/files/documents/stiff-person-syndrome_1.DOCX 39150 626 0.727552333
/system/files/documents/stiff-person-syndrome_1.PDF 142533 0 0.725472473
/system/files/documents/Strategic%20Framework%20for%20National%20Haemovigilance%20Program%20.docx 1089146 15507 0.638348003
/system/files/documents/Strategic%20Framework%20for%20National%20Haemovigilance%20Program%20.pdf 498024 0 0.730247872
/system/files/documents/sue-quiring-and-nadine-verdoorn-the-joys-trials-and-tribulations-of-a-multidisciplinary-laboratory-2013-session-5-speaker-3.pdf 4123010 0 0.772632912
/system/files/documents/summary-stakeholder-responses-ig_0.pdf 217309 0 1.130517998
/system/files/documents/summary-stakeholder-responses-ig.docx 150725 1458 1.02084244
/system/files/documents/summary-stakeholder-responses-iprp.docx 162674 1766 1.137718538
/system/files/documents/summary-stakeholder-responses-iprp.pdf 240110 0 1.170004559
/system/files/documents/supplier-contacts-for-rcdp-orders.docx 19016 252 0.968836187
/system/files/documents/supplier-contacts-for-rcdp-orders.pdf 62014 0 1.027295859
/system/files/documents/SWING%20TAGS_1.pdf 75525 0 0.630771722
/system/files/documents/SWING%20TAGS_2_0.pdf 15968 0 0.791278773
/system/files/documents/SWING%20TAGS_3.pdf 59511 0 0.728771451
/system/files/documents/SWING%20TAGS_4_0.pdf 16122 0 0.75971234
/system/files/documents/SWING%20TAGS_5.pdf 69128 0 0.830584182
/system/files/documents/SWING%20TAGS_6.pdf 16071 0 0.771522432
/system/files/documents/tara-kahlyar-rcpa-qap-transfusion-program-2013-session-4-speaker-2.pdf 4278723 0 0.724441237
/system/files/documents/tim-wilmott-idiotic-versus-idiopathic-cold-agglutinin-disease-2012-session-1-speaker-9.pdf 749740 0 0.66540972
/system/files/documents/tony-greenfield-a-new-way-to-manage-your-remote-blood-fridges-the-rfid-smart-fridge-2013-session-4-speaker-1-reduced_2.pdf 731405 0 0.556526016
/system/files/documents/tony-greenfield-daring-stunt-goes-wrong-2012-session-6-speaker-5.pdf 2471055 0 0.83445431
/system/files/documents/tony-greenfield-phenotyping-what%20s-expected-2011-session-3-speaker-8_0.pdf 1601603 0 0.702144117
/system/files/documents/toxic-epidermal-necrolysis-%28ten-lyell-syndrome%29-stevens%E2%80%93johnson-syndrome%28sjs%29_0.DOCX 61245 1038 0.767491941
/system/files/documents/toxic-epidermal-necrolysis-%28ten-lyell-syndrome%29-stevens%E2%80%93johnson-syndrome%28sjs%29_0.PDF 140751 0 0.781566974
/system/files/documents/toxic-shock-syndrome%28tss%29_0.DOCX 65287 1206 0.841205436
/system/files/documents/toxic-shock-syndrome%28tss%29_0.PDF 208805 0 0.849446734
/system/files/documents/transcript-ashford-hospital.docx 20825 346 1.106296384
/system/files/documents/transcript-ashford-hospital.pdf 54165 0 1.182195006
/system/files/documents/transcript-blood-fridge_0.pdf 53905 0 0.968383129
/system/files/documents/transcript-blood-fridge.docx 20770 354 0.876205084
/system/files/documents/transcript-bloodmove.docx 23731 423 0.925372178
/system/files/documents/transcript-bloodmove.pdf 64661 0 1.040041709
/system/files/documents/transcript-kapunda.docx 21910 358 0.937261002
/system/files/documents/transcript-kapunda.pdf 58591 0 1.081524171
/system/files/documents/transcript-video-from-rbwh.docx 21540 325 0.821045448
/system/files/documents/transcript-video-from-rbwh.pdf 26925 0 1.111774748
/system/files/documents/transcript-video-from-townsville.docx 21353 376 0.700780182
/system/files/documents/transcript-video-from-townsville-education.docx 21015 371 0.711747944
/system/files/documents/transcript-video-from-townsville-education.pdf 26499 0 2.121873118
/system/files/documents/transcript-video-from-townsville.pdf 26767 0 0.791728995
/system/files/documents/transcript-wastage-ownership_0.docx 22878 367 0.932990493
/system/files/documents/transcript-wastage-ownership_0.pdf 62452 0 1.134516958
/system/files/documents/Updated-bloodportal-tipsheet-create-account_1.docx 684390 11909 1.110436124
/system/files/documents/Updated-bloodportal-tipsheet-create-account_1.pdf 489653 0 1.365808986
/system/files/documents/using-the-inventory-tab-for-fate.docx 1077237 16384 0.616801265
/system/files/documents/using-the-inventory-tab-for-fate.pdf 172823 0 0.722785427
/system/files/documents/V6-Standing-Offer-for-the-Supply-of-Red-Cell-Diagnostic-Products-to-Public-Laboratories-Operating-Procedures.docx 3060490 18768 1.066822759
/system/files/documents/V6-Standing-Offer-for-the-Supply-of-Red-Cell-Diagnostic-Products-to-Public-Laboratories-Operating-Procedures.pdf 162272 0 0.73682864
/system/files/documents/van-nguyen-out-of-africa-case-study-anti-fy3-2010-session-1-speaker-6.PDF 4580495 0 0.6044991
/system/files/documents/vaughan-davies-and-jackie-daley-2013-session-3-speaker-8-a-rare-indian-a-case-study-from-the-act.pdf 2019228 0 1.142350611
/system/files/documents/video1packaging-2.mp4 50947763 0 1.040225377
/system/files/documents/video2tsvtransfers-2.mp4 31640874 0 0.746004067
/system/files/documents/video3tsveducation-2.mp4 26285456 0 0.790190801
/system/files/documents/wa-health-provider-blood-and-blood-products-expectations-gps_0.pdf 500868 0 0.586617116
/system/files/documents/wa-health-provider-blood-and-blood-products-expectations-gps.docx 969506 13393 0.759343062
/system/files/documents/wa-health-provider-blood-and-blood-products-expectations-hospitals_0.pdf 453818 0 0.650302109
/system/files/documents/wa-health-provider-blood-and-blood-products-expectations-hospitals.docx 971065 13479 0.713885187
/system/files/documents/wa-health-provider-expectations-laboratories_0.pdf 450981 0 0.688379896
/system/files/documents/wa-health-provider-expectations-laboratories.docx 970278 13543 0.645785737
/system/files/documents/web-education-and-information-advisory-group-tor.docx 286945 5269 0.807782137
/system/files/documents/web-education-and-information-advisory-group-tor.pdf 213099 0 0.700042351
/system/files/documents/word-version-preoperative-bleeding-qrg.docx 144563 2641 2.118044572
/system/files/EHL-framework.pdf 241731 0 2.187800011
/system/files/EHL-patient-info-sheet.pdf 218124 0 1.103332796
/system/files/Epidermolysis-bullosa-acquisita2017.docx 59338 1136 0.621587279
/system/files/Epidermolysis-bullosa-acquisita2017.pdf 445768 0 0.934783579
/system/files/FAQs-for-R2-RD-Grant-Applications.DOCX 799759 15621 1.651218494
/system/files/FAQs-for-R2-RD-Grant-Applications.pdf 379450 0 0.704985068
/system/files/Fetal-and-neonatal-alloimmune-thrombocytopenia%28FNAIT%292017.docx 60669 1053 0.760664906
/system/files/Fetal-and-neonatal-alloimmune-thrombocytopenia%28FNAIT%292017.pdf 449671 0 1.02415654
/system/files/File-title-List-Jan-to-June-2017.pdf 65042 0 0.81299399
/system/files/File-Title-List-july-to-Dec-2016.xlsx 11226 187 0.664560856
/system/files/Funding-and-Services-Agreement.pdf 159420 0 1.027522317
/system/files/Graves-ophthalmopathy2017.docx 61007 1098 0.68638224
/system/files/Graves-ophthalmopathy2017.pdf 437908 0 0.979963489
/system/files/HAC-Membership.pdf 65148 0 1.070312346
/system/files/HAC-Terms-of-Reference.pdf 206696 0 1.220264557
/system/files/Haematology-Summary-of-Changes.docx 28972 511 1.128067022
/system/files/Haematology-Summary-of-Changes.pdf 288709 0 1.336611545
/system/files/Haemolytic-disease-of-the-fetus%28previously-Haemolytic-disease-of-the-fetus-and-newborn%292017.docx 62422 1217 0.691953132
/system/files/Haemolytic-disease-of-the-fetus%28previously-Haemolytic-disease-of-the-fetus-and-newborn%292017.pdf 443103 0 0.845121164
/system/files/Haemolytic-transfusion-reaction-not-associated-with-red-cell-antibodies2017.docx 59147 1092 0.701648462
/system/files/Haemolytic-transfusion-reaction-not-associated-with-red-cell-antibodies2017.pdf 429020 0 0.863609273
/system/files/HaemophiliaGuidelines-interactive-updated-260317v2.pdf 2706107 0 1.072863422
/system/files/Hashimoto%E2%80%99s-encephalopathy2017.docx 48347 900 0.727565753
/system/files/Hashimoto%E2%80%99s-encephalopathy2017.pdf 401655 0 0.824282413
/system/files/HIV-in-children2017.docx 42472 738 0.68459492
/system/files/HIV-in-children2017.pdf 372612 0 0.688783377
/system/files/Hospitals-participating-in-the-National-SCIg-program-22Mar2018.pdf 95562 0 1.287690563
/system/files/Hospitals-participating-in-the-National-SCIg-program-22Mar2018.xlsx 21063 342 0.91529318
/system/files/Ig-Governance-SWG-Terms-of-Reference-June-2016.docx 62987 1118 0.715758869
/system/files/Ig-Governance-SWG-Terms-of-Reference-June-2016.pdf 407055 0 0.886975084
/system/files/Immunoglobulin-products-available-under-JDO.docx 51512 878 1.10521068
/system/files/Immunoglobulin-products-available-under-JDO.pdf 223421 0 1.073264532
/system/files/Immunology-Summary-of-Changes.docx 30128 483 0.738153158
/system/files/Immunology-Summary-of-Changes.pdf 290402 0 0.750186199
/system/files/IVIg-Authorisation-Request-for-Haematological-Indications-Feb2017.dot 161280 0 0.722918698
/system/files/IVIg-Authorisation-Request-for-Haematological-Indications-Feb2017.pdf 336001 0 0.719378444
/system/files/IVIg-Authorisation-Request-for-Immunological-or-General-Indications-Feb2017.dot 163328 0 0.724392268
/system/files/IVIg-Authorisation-Request-for-Immunological-or-General-Indications-Feb2017.pdf 337520 0 0.738843987
/system/files/IVIg-Authorisation-Request-for-Neurological-Indications-Feb2017.dot 164352 0 0.744601467
/system/files/IVIg-Authorisation-Request-for-Neurological-Indications-Feb2017.pdf 337038 0 0.643224671
/system/files/IVIg-Authorisation-Request-for-Renal-Indications-Feb2017.dot 156160 0 0.924886106
/system/files/IVIg-Authorisation-Request-for-Renal-Indications-Feb2017.pdf 333257 0 0.714524911
/system/files/John-Hunter.pdf 1419940 0 1.30856864
/system/files/Kidney-transplantation2017.docx 76607 1464 0.728864373
/system/files/Kidney-transplantation2017.pdf 525900 0 0.767606628
/system/files/Limbic-encephalitis-non-paraneoplastic-and-paraneoplastic2017.docx 50381 970 0.695441335
/system/files/Limbic-encephalitis-non-paraneoplastic-and-paraneoplastic2017.pdf 394574 0 0.677174313
/system/files/List-of-Contracts-for-the-2016-Calendar-Year-Response-to-Senate-Order192-Murray-Motion.pdf 66752 0 0.723230703
/system/files/List-of-Contracts-for-the-2016-Calendar-Year-Response-to-Senate-Order192-Murray-Motion.xlsx 11374 177 0.62342894
/system/files/MakinganInitialAuthorisationRequest.docx 701385 12628 0.750583721
/system/files/MakinganInitialAuthorisationRequest.pdf 565189 0 0.635899191
/system/files/module1-managing-blood-and-blood-product-transfers.pdf 4486046 0 1.044665955
/system/files/Module2-Ig-Inventory-Management-Guideline.pdf 850632 0 0.974364357
/system/files/Module-2-Ig-Inventory-Management-Guidelines.docx 1263400 22195 1.099345455
/system/files/Module6-AppendixH-Paediatric-haemoglobin-assessment-and-optimisation-template-1Feb2016-UPDATED-Jan2017.pptx 6751959 132555 1.078178481
/system/files/Module6-AppendixK-Critical-bleeding-protocol-1Feb2016-UPDATED-Jan2017.pptx 6760460 132634 1.87178548
/system/files/Module6-TRV1-FINAL-updated-27Nov15.PDF 8655542 0 0.770439077
/system/files/Module6-TRV2-FINAL-updated-27Nov15.PDF 10434336 0 1.217447828
/system/files/Myocarditis-in-children2017.docx 44147 758 0.769747703
/system/files/Myocarditis-in-children2017.pdf 377918 0 0.577395771
/system/files/National-Blood-Authority-Fact-sheet-Supply-of-plasma-derived-and-recombinant-blood-products1Jan2018.docx 42260 821 1.042651142
/system/files/National-Blood-Authority-Fact-sheet-Supply-of-plasma-derived-and-recombinant-blood-products-1Jan2018.pdf 256624 0 1.307207622
/system/files/National-Immunoglobulin-Governance-Advisory-Committee%28NIGAC%29-Nov%202017.pdf 265222 0 0.807610462
/system/files/National-Patient-Blood-Management-Strategy-2017-2021-Final.docx 217400 3083 1.157054789
/system/files/National-Patient-Blood-Management-Strategy-2017-2021-Final.pdf 670354 0 1.130416491
/system/files/NBA-A3-Poster-10-tips-to-inventory.pdf 164905 0 1.330398543
/system/files/NBA-Corporate-Plan-2017-18to2020-21-FINAL-20171115.docx 2990072 44454 0.83363766
/system/files/NBA%E2%80%932016-17RMG403-Accountable-Authority-Assurance.pdf 473600 0 0.79511653
/system/files/Neurology-Summary-of-Changes.docx 29945 493 0.667639698
/system/files/Neurology-Summary-of-Changes.pdf 213721 0 0.849332305
/system/files/Neuromyelitis-optica-spectrum-disorders-%28previously-known-as-Devic-disease%292017.docx 61072 1136 0.777948857
/system/files/Neuromyelitis-optica-spectrum-disorders-%28previously-known-as-Devic-disease%292017.pdf 430407 0 0.657921028
/system/files/NICE-2017-Registration-Info.pdf 895817 0 1.02537096
/system/files/nigac-terms-of-reference.pdf 350529 0 1.282516221
/system/files/OBFM.pdf 305585 0 1.067583681
/system/files/Paediatric-and-Neonatal-Iron-Deficiency-Anaemia-Guide-Final-Dec17.docx 2550339 37769 1.58572882
/system/files/Paediatric-and-Neonatal-Iron-Deficiency-Anaemia-Guide-Final-Dec17.pdf 237232 0 0.813873411
/system/files/Paediatric-autoimmune-neuropsychiatric-disorder-associated-with-streptococcal-infection-%28PANDAS%292017.docx 60506 1024 0.749491015
/system/files/Paediatric-autoimmune-neuropsychiatric-disorder-associated-with-streptococcal-infection-%28PANDAS%292017.pdf 452301 0 0.691573833
/system/files/Paraneoplastic-syndromes2017.docx 45818 898 0.727308285
/system/files/Paraneoplastic-syndromes2017.pdf 390983 0 0.64954414
/system/files/Patient-Privacy-Consent-form-Aug.docx 1112525 20558 0.793325088
/system/files/Patient-Privacy-Consent-Form-Aug.pdf 233663 0 0.73073851
/system/files/Potassium-channel-antibody-associated-encephalopathy2017.docx 44266 782 0.781787347
/system/files/Potassium-channel-antibody-associated-encephalopathy2017.pdf 377351 0 0.611698675
/system/files/Privacy-Statement-and-Notice18082015.pdf 246872 0 0.679096504
/system/files/privacy-statement-and-notice.docx 119179 2106 0.77991483
/system/files/Pure-red-cell-aplasia2017.docx 60022 1016 0.708804884
/system/files/Pure-red-cell-aplasia2017.pdf 425948 0 0.66141988
/system/files/Pure-white-cell-aplasia2017.docx 47129 871 0.731196887
/system/files/Pure-white-cell-aplasia2017.pdf 397685 0 0.6512781
/system/files/Pyoderma-gangrenosum2017.docx 65627 1188 0.667059513
/system/files/Pyoderma-gangrenosum2017.pdf 444811 0 0.631559513
/system/files/Rasmussen-syndrome2017.docx 57468 1049 0.679092905
/system/files/Rasmussen-syndrome2017.pdf 420801 0 0.795118232
/system/files/recruitment_application_coversheet_may2017.docx 162433 1715 2.215405763
/system/files/recruitment_application_coversheet_may2017.pdf 410820 0 1.287501679
/system/files/Registration%20form%20NICE%202017.pdf 308094 0 1.080515815
/system/files/Report-on-the-Issues-and-Use-of-IVIg-2014-15-Final_v2.docx 10282183 188081 1.309853835
/system/files/Report-on-the-Issues-and-Use-of-IVIg-2014-15-Final-v2.pdf 1971777 0 0.866516834
/system/files/Report-on-the-Issues-and-Use-of-IVIg-2015-16-Final-V3.docx 5965701 101618 0.825178555
/system/files/Report-on-the-Issues-and-Use-of-IVIg-2015-16-Final-V3.pdf 2201791 0 2.761686055
/system/files/Revision-register-Guidelines-for-the-management-of-the-haemophilia-in-Australia.pdf 71218 0 1.101675006
/system/files/Revision-register-Guidelines-for-the-management-of-the-haemophilia-in-Australia.xlsx 11387 188 0.842550445
/system/files/SCIg-Authorisation-Request-for-Haematological-Indications-Feb2017.dot 154112 0 1.139340952
/system/files/SCIg-Authorisation-Request-for-Haematological-Indications-Feb2017.pdf 331675 0 1.471084457
/system/files/SCIg-Authorisation-Request-for-Immunological-Indications-Feb2017.dot 161280 0 0.662674511
/system/files/SCIg-Authorisation-Request-for-Immunological-Indications-Feb2017.pdf 335964 0 0.763266264
/system/files/Scleromyxedema2017.docx 58936 1112 0.70232694
/system/files/Scleromyxedema2017.pdf 441563 0 0.625760303
/system/files/Sector-Monitoring-August-September-2016-at-20-Sept.docx 80412 1442 0.727777801
/system/files/Sector-Monitoring-August-September-2016-at-20-Sept.pdf 802351 0 0.570007213
/system/files/sector-monitoring-jan-2017.docx 210461 3914 0.672106322
/system/files/sector-monitoring-jan-2017.pdf 909265 0 0.646206333
/system/files/Sector-Monitoring-June-July-2016-at-31-July.docx 90637 1649 0.72097058
/system/files/Sector-Monitoring-June-July-2016-at-31-July.pdf 812799 0 0.645188271
/system/files/Sector-Monitoring-May-2016-at-31-May.docx 93447 1746 0.623501026
/system/files/Sector-Monitoring-May-2016-at-31-May.pdf 909035 0 0.7520768
/system/files/sector-monitoring-nov-dec-2016.docx 139854 2617 0.627015779
/system/files/sector-monitoring-nov-dec-2016.pdf 833333 0 0.769004984
/system/files/sector-monitoring-report-February2017.docx 86114 1647 0.814723946
/system/files/sector-monitoring-report-February2017.pdf 951946 0 0.780139724
/system/files/sector-monitoring-report-june-july-2017.docx 103901 1913 0.785688814
/system/files/sector-monitoring-report-june-july-2017.pdf 768231 0 0.999062425
/system/files/sector-monitoring-report-oct-nov-2017.docx 109596 2067 0.713696602
/system/files/sector-monitoring-report-oct-nov-2017.pdf 802968 0 0.719939827
/system/files/sector-monitoring-report-webpost-Aug-Sept-2017.docx 114103 2209 0.772475248
/system/files/sector-monitoring-report-webpost-Aug-Sept-2017.pdf 831183 0 2.248255287
/system/files/Senate-File-Title-List-July-to-Dec-2017.pdf 45468 0 0.825007003
/system/files/Senate-File-Title-List-July-to-Dec-2017.xlsx 11112 175 0.552947083
/system/files/Sjogren%E2%80%99s-syndrome2017.docx 65718 1204 0.793677292
/system/files/Sjogren%E2%80%99s-syndrome2017.pdf 469153 0 0.635371062
/system/files/Solid-organ-transplantation-other-than-kidney2017.docx 71050 1299 0.673262016
/system/files/Solid-organ-transplantation-other-than-kidney2017.pdf 467160 0 0.733564189
/system/files/Susac-syndrome2017.docx 53663 1000 0.728506486
/system/files/Susac-syndrome2017.pdf 424712 0 0.697513361
/system/files/SVTs-at-FMC-case-study-v2-with-endnote-references.pdf 448721 0 1.179064063
/system/files/Systemic-capillary-leak-syndrome2017.docx 51249 947 0.69617958
/system/files/Systemic-capillary-leak-syndrome2017.pdf 417963 0 0.7268457
/system/files/Transplantation-Summary-of-Changes.docx 28662 492 0.720806795
/system/files/Transplantation-Summary-of-Changes.pdf 224247 0 0.722195417
Temporary Employment Register | National Blood Authority /temporary-employment-register 61598 1216 0.918340464
Toowoomba | National Blood Authority /toowoomba 68671 1483 1.701132077
Townsville | National Blood Authority /townsville 71833 1798 0.919861512
Treating Anaemia and Managing Iron | National Blood Authority /treating-anaemia-and-managing-iron 60155 1156 1.635761831
Update to Supply Arrangements for Domestic Intravenous Immunoglobulin | National Blood Authority /update-supply-arrangements-domestic-intravenous-immunoglobulin 57153 845 1.004157257
Vendor Certification Process | National Blood Authority /vendor-certification-process 75478 2204 1.711150167
vOffice | National Blood Authority /voffice 56107 864 1.639096872
National Blood and Blood Product Wastage Reduction Strategy 2013-17 | National Blood Authority /wastage 69727 1732 2.497926873
Who are Burnside and BloodSafe? | National Blood Authority /who-are-burnside-and-bloodsafe 67769 1187 1.056357388
Who will access BloodSTAR? | National Blood Authority /who-will-access-bloodstar 63829 1140 1.290253694